Experiments for taxon Ginkgo biloba (GINKGOACEAE)

Experiments (2531 results)

Filters
Worktypes (75)
548
537
312
258
240
232
174
171
152
138
102
97
87
86
80
68
55
54
51
49
47
46
42
29
29
27
18
18
13
13
13
12
11
10
10
10
9
8
8
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (301)
103
96
73
49
48
45
42
36
36
33
32
27
27
27
23
23
20
19
19
18
16
16
14
13
12
12
11
11
11
11
10
10
10
9
9
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
774
No match
107 rarer values not listed
Compounds (301)
146
118
88
79
35
33
33
31
30
29
27
24
21
20
19
19
18
16
15
12
12
12
11
10
9
8
8
7
7
7
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1677
No match
201 rarer values not listed
Organisms (300)
59
51
46
41
39
20
18
17
17
16
15
15
15
13
12
12
12
11
11
10
10
9
9
9
9
9
8
8
8
8
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
No match
1031 rarer values not listed
2531 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
684604
PRESENT IN (REVIEW)REVIEW OF
Ginkgo biloba (GINKGOACEAE)
POLYPRENOLS
67042
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
969152
PHARMACOLOGY OF EXTRACT - IN VIVO
RECEPTOR BINDING STIMULANT
Ginkgo biloba (GINKGOACEAE)
954787
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
68827
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
809349
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACIDS
1167908
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1183970
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACID
687284
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
521830
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
769720
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDYREVIEW OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
1032543
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACIDS
659858
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-(6'''-PARA-COUMAROYL-GLUCOSYL(1-2)-RHAMNOSIDE)QUERCETIN-3-O-RHAMNOSYL(1-2)-RHAMNOSYL(1-6)-GLUCOSIDERUTINRHAMNETIN,ISO: 3-O-(6'''-PARA-COUMAROYL-GLUCOSYL(1-2)-RHAMNOSIDE)RHAMNETIN,ISO: 3-O-RUTINOSIDERHAMNETIN,ISO: 3-O-RHAMNOSYL(1-2)-RHAMNOSYL(1-6)-GLUCOSIDEKAEMPFEROL-3-O-(6'''-PARA-COUMAROYL-GLUCOSYL(1-2)-RHAMNOSIDE)KAEMPFEROL-3-O-RHAMNOSYL(1-2)-RHAMNOSYL(1-6)-GLUCOSIDE
760414
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
369676
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
802515
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1304058
CLINICAL STUDIES
DIABETIC RETINOPATHY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
762463
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
763027
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
704846
PHARMACOLOGY OF EXTRACT - IN VIVO
VASCULAR PERMEABILITY DECREASED
Ginkgo biloba (GINKGOACEAE)
603331
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
756038
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
394681
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
870442
PHARMACOLOGY OF EXTRACT - IN HUMANS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1295228
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
MOLLUSCICIDAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280576
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
713868
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROTEIN
786224
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
552892
PHARMACOLOGY OF EXTRACT - IN VIVO
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
729531
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLRHAMNETIN,ISO:
349386
PHARMACOLOGY OF EXTRACT - IN VIVO
GLYCOGEN CONTENT INCREASED
Ginkgo biloba (GINKGOACEAE)
588234
PHARMACOLOGY OF EXTRACT - IN VIVO
CATECHOLAMINE-RELEASING EFFECT
Ginkgo biloba (GINKGOACEAE)
67482
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
68523
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
803744
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1031729
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
THYMOLBENZENE,1-4-DIMETHYL-2-5-DIISO-PROPYL:CYMENE,PARA:PROPYLENE,(PARA-TOLYL):HEPTADECA-3-6-9-TRIEN-1-OLPHENOL,2-ISO-PROPYL:ACENAPHTHENEHEX-CIS-4-EN-1-OLHEX-TRANS-4-EN-1-OLIONONE,BETA:HEX-CIS-3-EN-1-OLLINALOOL,TRANS: OXIDENAPHTHALENE,DIHYDRO: 2-5-8-TRIMETHYL:
278018
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNPYRANOSIDE
652753
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
551298
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTAMATE RECEPTOR BLOCKER
Ginkgo biloba (GINKGOACEAE)
402999
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
280226
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETINSCIADOPITYSIN
1275723
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
280233
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SESAMIN
398124
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
635083
PHARMACOLOGY OF EXTRACT - IN VIVO
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
239292
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGO GLYCOPROTEIN
673867
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
725998
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPHAGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
706584
PHARMACOLOGY OF EXTRACT - IN VIVO
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
280240
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-RHAMNOGLUCOSIDE
798328
PHARMACOLOGY OF EXTRACT - IN VITRO
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
870950
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
673844
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
902518
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
635002
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
760403
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMARYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
788186
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
638841
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
POLYPHENOLOXIDASE
794482
PHARMACOLOGY OF EXTRACT - IN VITRO
ALDOSE REDUCTASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
488738
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFIBRINOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167895
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
756234
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1278847
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
654602
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
897460
PHARMACOLOGY OF EXTRACT - IN VITRO
GLYCOGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
626996
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
396531
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
7434
IDENTIFICATION IN BY GLC AFTER SAPONIFICATION
Ginkgo biloba (GINKGOACEAE)
STIGMASTEROLSITOSTEROL,BETA:
393780
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
SEQUOIAFLAVONEAMENTOFLAVONEGINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
68972
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1278836
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
388498
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
395422
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
MANGANESE
803747
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
948427
CLINICAL STUDIES
BLOOD SYSTEM EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
695493
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
626578
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
678979
PHARMACOLOGY OF COMPOUND - IN VITRO
NOREPINEPHRINE LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
261138
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
393346
PHARMACOLOGY OF EXTRACT - IN VIVO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
351323
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINGINKGOLGINKGOIC ACID,HYDRO:GINNOL
1178919
PHARMACOLOGY OF EXTRACT - IN VITRO
CATECHOLAMINE-RELEASING EFFECT
Ginkgo biloba (GINKGOACEAE)
874487
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
962842
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
LARICITRIN-3-O-RUTINOSIDE
1300834
PHARMACOLOGY OF EXTRACT - IN VITRO
BETA-SECRETASE ENZYME INHIBITION
Ginkgo biloba (GINKGOACEAE)
280204
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
MYRICETIN,4'-O-METHYL: 3-O-(6-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
1179453
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
LIPID PEROXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
885249
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN
668324
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-RHAMNOSIDE
589632
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394622
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
7739
PHARMACOLOGY OF EXTRACT - IN VITRO
MALATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
942183
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
DOLICHOL
626725
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
95408
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
973496
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
739742
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE ADELPHINIDINGINKGOLIDE BCYANIDIN
517022
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
704594
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN EXPRESSION INHIBITION
Ginkgo biloba (GINKGOACEAE)
1021833
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHEMOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
993316
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
394331
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
363190
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
915001
PHARMACOLOGY OF EXTRACT - IN VIVO
ATP LEVELS INCREASED
Ginkgo biloba (GINKGOACEAE)
391501
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
1281277
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69494
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
808266
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
400361
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
ASPARAGINEGLUTAMINEALANINE,PHENYL:LEUCINETYROSINELEUCINE,ISO:PROLINEALANINEGLYCINE
870949
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-HEPTADECENYL:
697915
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACIDPROTOCATECHUIC ACIDFERULIC ACIDCOUMARIC ACID,PARA:CHLOROGENIC ACID
470769
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
796686
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
266020
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
THERMOPSOSIDE
278002
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-BALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
1288821
PHARMACOLOGY OF EXTRACT - IN VIVO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
1304095
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
370927
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
678972
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
737233
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO:
66791
CLINICAL STUDIES
BLOOD VISCOSITY DECREASED
Ginkgo biloba (GINKGOACEAE)
705461
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
775730
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE B
1183001
PHARMACOLOGY OF EXTRACT - IN VIVO
ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)
Ginkgo biloba (GINKGOACEAE)
802572
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1167897
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697931
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CHLOROGENIC ACID
654794
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ESTERASE ISOZYMESPEROXIDASE ISOZYMES
46190
PLANT TISSUE CULTURE MARKER CODEREVIEW OF
Ginkgo biloba (GINKGOACEAE)
973743
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
924075
CLINICAL STUDIES
HYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789079
PHARMACOLOGY OF EXTRACT - IN VITRO
LACTATE DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
803189
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN,2-3-DIHYDRO:
1301053
PHARMACOLOGY OF COMPOUND - IN VITRO
HIV PROTEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
ALKYLSALICYLIC ACID C-15:1
397391
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
359748
PHARMACOLOGY OF EXTRACT - IN VIVO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
765084
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
803190
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN,2-3-DIHYDRO:
758670
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
775718
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR NECROSING FACTOR SECRETION INHIBITION
Ginkgo biloba (GINKGOACEAE)
761872
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
394778
CLINICAL STUDIES
FIBRINOGEN LEVEL DECREASED
Ginkgo biloba (GINKGOACEAE)
821743
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
398114
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278029
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
1284279
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
1007028
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
POPULNIN
673839
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1303598
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
798453
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
397389
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
TERATOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1284911
CLINICAL STUDIES
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
1301042
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
CARDANOL C-17:1
398381
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLIC AMP PHOSPHODIESTERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1167886
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
721507
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
FARNESYL ACETONE,HEXAHYDRO:
361929
PHARMACOLOGY OF EXTRACT - IN VIVO
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
802934
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1167878
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
625854
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
316714
MEDICINAL FOLKLORE REPORTED FOR
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
788690
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
397380
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
280215
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
APIGENIN,4'-O-METHYL:
639648
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
547403
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
673837
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
636675
PHARMACOLOGY OF EXTRACT - IN VIVO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
261129
AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
644626
PHARMACOLOGY OF EXTRACT - IN HUMANS
ERECTILE DYSFUNCTION TREATMENT
Ginkgo biloba (GINKGOACEAE)
639682
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
67736
PHARMACOLOGY OF COMPOUND - IN HUMANSREVIEW OF
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDBILOBOL
445503
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
453787
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
697866
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIALCOHOLIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
955355
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-COUMAROYL-GLUCORHAMNOSIDEGINKGETIN,ISO:QUERCITRIN,ISO:RUTINGINKGETINBILOBETINSCIADOPITYSIN
929060
CLINICAL STUDIES
BLOOD VISCOSITY DECREASED
Ginkgo biloba (GINKGOACEAE)
673857
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638798
PHARMACOLOGY OF EXTRACT - IN VITRO
COLLAGEN FIBRIL(TYPE I)RETICULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
738566
PHARMACOLOGY OF EXTRACT - IN VITRO
VASORELAXATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
547824
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1198892
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167902
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
639687
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIAGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1139315
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMUTAGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
637561
CLINICAL STUDIES
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397132
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1318083
PHARMACOLOGY OF COMPOUND - IN HUMANS
IMMUNOMODULATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
397320
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
738691
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
794713
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIATHEROSCLEROTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
813180
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
CATECHIN,(+):
808389
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
1323036
PHARMACOLOGY OF EXTRACT - IN VIVO
NOCICEPTIVE RESPONSE REDUCTION
Ginkgo biloba (GINKGOACEAE)
67448
PHARMACOLOGY OF EXTRACT - IN HUMANS
HEMORRHAGIC EFFECT
Ginkgo biloba (GINKGOACEAE)
441208
PHARMACOLOGY OF EXTRACT - IN HUMANS
RBC DEFORMABILITY INCREASE
Ginkgo biloba (GINKGOACEAE)
401728
IDENTIFICATION IN BY LC/MSWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
1167875
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1050792
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINBILOBETINACACETINSCIADOPITYSIN
874516
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
607643
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
163056
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
COUMARIN,ISO: 8-HYDROXY-3-(6'-PENTADECENYL)-3-4-DIHYDRO:
806722
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
369423
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCITRINKAEMPFEROL-3-O-[6-O-ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]RHAMNETIN,ISO: 3-O-[2-O-6-O-BIS(ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]QUERCETIN-3-O-[2-O-(6-O-(PARA-HYDROXY-CINNAOMYL)-BETA-D-GLUCOSYL]-ALPHA-L-RHAMNOSIDE]LUTEOLINAMENTOFLAVONEQUERCETIN-3-O-[6-O-(ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]QUERCETINLUTEOLIN-3'-O-BETA-D-GLUCOSIDEGINKGETIN,ISO:ASTRAGALINRHAMNETIN,ISO: 3-O-BETA-D-GLUCOSIDEQUERCETIN-3-O-[2-O-[6-O-(PARA-HYDROXY-TRANS-CINNAMOYL)-BETA-D-GLUCOSYL]-ALPHA-L-RHAMNOSIDEKAEMPFEROL-3-O-[2-O-(BETA-D-GLUCOSYL)-ALPHA-L-RHAMNOSIDE]QUERCITRIN,ISO:COSMOSIINKAEMPFEROLQUERCETIN-3-O-[6-O-(PARA-(BETA-D-GLUCOSYL)-OXY-TRANS-CINNAMOYL]-BETA-D-GLUCOSYL]-ALPHA-L-RHAMNOSIDE)MYRICETINGINKGETINBILOBETINQUERCETIN-3-O-[2-O-6-O-BIS-(ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]KAEMPFEROL-3-O-ALPHA-L-RHAMNOSIDEKAEMPFEROL-3-O-(2-O-[6-O-[PARA-(BETA-D-GLUCOSYL)-OXY-TRANS-CINNAMOYL]-BETA-D-GLUCOSYL]-ALPHA-L-RHAMNOSIDE]MYRICETIN,3'-METHYL: 3-O-[6-O-ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]QUERCETIN-3-O-[2-O-BETA-D-GLUCOSYL)-ALPHA-L-RHAMNOSIDE]SCIADOPITYSINKAEMPFEROL-3-O-[2-O-[6-O-(PARA-HYDROXY-TRANS-CINNAMOYL-BETA-D-GLUCOSYL]-ALPHA-L-RHAMNOSIDE]KAEMPFEROL-3-O-[2-O-6-O-BIS-(ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]RHAMNETIN,ISO:APIGENINMYRICETIN-3-O-[6-O-(ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]RHAMNETIN,ISO: 3-O-[6-O-(ALPHA-L-RHAMNOSYL)-BETA-D-GLUCOSIDE]
697917
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
897280
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
280244
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-GLUCORHAMNOSIDE
629120
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
680722
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE FORMATION INDUCTION
Ginkgo biloba (GINKGOACEAE)
67731
PHARMACOLOGY OF EXTRACT - IN HUMANS
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1273731
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIAGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278000
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]-7-O-BETA-D-GLUCOPYRANOSIDE
397368
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1300467
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1201707
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697959
MASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBOL
394633
CLINICAL STUDIES
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
67854
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
697928
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
COUMARIC ACID,PARA:
605126
MEDICINAL FOLKLORE REPORTED FOR
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
218700
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYSACCHARIDE AGINKGO POLYSACCHARIDE B
771288
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PLATELET ACTIVATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
635094
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
723240
PHARMACOLOGY OF EXTRACT - IN VIVO
FREE RADICAL FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
352233
PHARMACOLOGY OF COMPOUND - IN VIVO
ALDOSTERONE DECREASE
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
673854
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
723154
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
705124
PHARMACOLOGY OF EXTRACT - IN VIVO
MYOCARDIAL ISCHEMIC IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
574022
PHARMACOLOGY OF EXTRACT - IN VITRO
TRANSCRIPTION INHIBITION
Ginkgo biloba (GINKGOACEAE)
724083
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
609667
PHARMACOLOGY OF EXTRACT - IN VIVO
CNS DEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
715895
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
391512
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
1249452
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ERGOSTEROLSITOSTEROL,BETA:
1276643
CLINICAL STUDIES
HEMATOLOGICAL EFFECTS
Ginkgo biloba (GINKGOACEAE)
605121
MEDICINAL FOLKLORE REPORTED FOR
ANTIASTHMATIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673840
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638805
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN FIBRIL(TYPE I)RETICULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
955660
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL ARTERIOSCLEROSIS SYMPTOMS DECREASED
Ginkgo biloba (GINKGOACEAE)
355791
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
719475
PHARMACOLOGY OF EXTRACT - IN VIVO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
741824
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
1255274
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ASCORBIC ACID
1085667
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NEMATOCIDAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397352
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
734728
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE AGINKGOLIDE B
396854
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-[HEPTADEC-CIS-10'-ENYL]:
1234341
PHARMACOLOGY OF EXTRACT - IN VIVOCARCINOGENIC DATA (MARKER CODE)
CARCINOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
700511
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDSTERPENE LACTONES
695676
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
635173
PHARMACOLOGY OF EXTRACT - IN VIVO
LONGEVITY PROLONGATION
Ginkgo biloba (GINKGOACEAE)
43594
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
BILOBANONE
1178341
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
387858
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
395415
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNITRINQUERCETINKAEMPFERITRIN
7526
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE A
977812
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ABSORPTION EFFECTS(CUTANEOUS)
Ginkgo biloba (GINKGOACEAE)
451020
PHARMACOLOGY OF EXTRACT - IN VIVO
GROWTH HORMONE INHIBITION
Ginkgo biloba (GINKGOACEAE)
642520
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1193218
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
424198
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-L-[BETA-D-GLUCOPYRANOSYL(1-2)RHAMNOPYRANOSIDE]
1017896
PHARMACOLOGY OF EXTRACT - IN VIVO
CELL MEMBRANE STABILIZER
Ginkgo biloba (GINKGOACEAE)
426359
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
68136
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
885241
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KYNURENIC ACID,6-HYDROXY:
278025
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
571526
PHARMACOLOGY OF EXTRACT - IN VITRO
OXIDATIVE BURST INHIBITION
Ginkgo biloba (GINKGOACEAE)
43591
YIELD IS MORE THAN 100 MGMWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SESAMIN,(+):
501166
PHARMACOLOGY OF EXTRACT - IN VITRO
CATALASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
460295
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPOLYDIPSIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280229
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
870955
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)
1004006
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM
Ginkgo biloba (GINKGOACEAE)
BILOBETIN,5'-METHOXY:
874483
CLINICAL STUDIES
ANTISHOCK EFFECT
Ginkgo biloba (GINKGOACEAE)
656951
QUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
PENTADECAN-2-ONE,6-10=14-TRIMETHYL:CEDRENE,ALPHA:BENZENE-1-2-DICARBOXYLIC ACIDCEDROLMETHYL-PROPYL ESTER,2-BUTYL:EUDESMOL,BETA:NEROLIDOLPALMITIC ACIDTETRADECANOIC ACID
349389
PHARMACOLOGY OF EXTRACT - IN VIVO
INSULIN LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
760409
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
316718
MEDICINAL FOLKLORE REPORTED FOR
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
805023
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
361926
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
394737
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
69617
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
766445
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ACACETIN
887052
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONE
971891
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
280211
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
558945
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANXIOLYTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
69560
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
1312839
CLINICAL STUDIESREVIEW OF
HYPOTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1296940
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
782803
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
954784
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
391505
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
705458
PHARMACOLOGY OF EXTRACT - IN VIVO
ANOXIA TOLERANCE INCREASED
Ginkgo biloba (GINKGOACEAE)
1167889
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
540223
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET ACTIVATING FACTOR BINDING INHIBITION
Ginkgo biloba (GINKGOACEAE)
885248
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
1167905
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
915005
PHARMACOLOGY OF EXTRACT - IN VIVO
MALONDIALDEHYDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
681046
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
671403
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1286822
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERLIPEMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
956204
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(6'''-PARA-COUMAROYL-GLUCOPYRANOSYL-BETA-1-4-RHAMNOPYRANOSIDE)QUERCETIN-3-O-(6'''-PARA-COUMAROYL-GLUCOPYRANOSYL-BETA-1-4-RHAMNOPYRANOSIDE)
67024
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280222
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGOLIDE JSESAMINSCIADOPITYSIN
392295
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE TRANSPORT STIMULATION
Ginkgo biloba (GINKGOACEAE)
395633
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
697935
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
352631
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
371231
PHARMACOLOGY OF EXTRACT - IN VITRO
LACTATE DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
789458
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
758739
PHARMACOLOGY OF EXTRACT - IN VIVO
LACTATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
654624
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
733796
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
809599
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
767800
PHARMACOLOGY OF EXTRACT - IN VIVO
TUMOR NECROSING FACTOR SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
424846
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATATLC DATA REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
TOCOPHEROL,GAMMA:
696782
IDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACIDVANILLIC ACIDBENZOIC ACID,4-HYDROXY:PROTOCATECHUIC ACIDFERULIC ACIDCOUMARIC ACID,PARA:CHLOROGENIC ACID
397387
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Ginkgo biloba (GINKGOACEAE)
700433
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE PEROXIDASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
1276659
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
636679
PHARMACOLOGY OF EXTRACT - IN VIVO
LONGEVITY PROLONGATION
Ginkgo biloba (GINKGOACEAE)
266019
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
LUTEOLIN-4'-O-BETA-D-GLUCOSIDE
1183005
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) RECEPTOR BINDING DECREASED
Ginkgo biloba (GINKGOACEAE)
564074
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-TRIDECYL:
882167
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(3'''-PARA-COUMAROYL-GLUCOSYL-BETA(1-4)-RHAMNOSIDE)
352240
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
647232
PHARMACOLOGY OF EXTRACT - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
COUMARIN,ISO: 3-4-DIHYDRO: 8-HYDROXY-3-(6'-PENTADECENYL): 3(R):
1258300
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
767881
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1296444
CLINICAL STUDIES
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
673878
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
537924
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BETULAPRENOL 17BETULAPRENOL 21BETULAPRENOL 19BETULAPRENOL 18BETULAPRENOL 15BETULAPRENOL 16BETULAPRENOL 20
397378
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1304118
CLINICAL STUDIES
ATTENTION DEFICIT IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
397384
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
76527
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
PYRIDOXINE,4'-METHOXY:
451024
PHARMACOLOGY OF EXTRACT - IN VIVO
DOPAMINE INCREASE
Ginkgo biloba (GINKGOACEAE)
695641
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
710996
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
441210
PHARMACOLOGY OF EXTRACT - IN HUMANS
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397363
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
370935
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
789084
PHARMACOLOGY OF COMPOUND - IN VITRO
LACTATE DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
715873
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-UNDECYL:OCTADECA-9-12-DIEN-1-ALEICOSANE,N:OCTADECAN-1-AL
67483
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
33951
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
738775
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673833
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
495844
PHARMACOLOGY OF EXTRACT - IN VITRO
SEROTONIN (5-HT) SECRETION INHIBITION
Ginkgo biloba (GINKGOACEAE)
715881
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-UNDECYL:OCTADECA-9-12-DIEN-1-ALEICOSANE,N:OCTADECAN-1-AL
685359
PHARMACEUTICAL FORMULATION OF A PLANT
Ginkgo biloba (GINKGOACEAE)
637566
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
794655
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
1304103
CLINICAL STUDIESREVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
445507
PHARMACOLOGY OF COMPOUND - IN VIVO
SLEEPING TIME DECREASED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE B
681337
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
362509
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
637559
CLINICAL STUDIES
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1284504
CLINICAL STUDIES
IMMUNOSTIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
407014
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBOL
354701
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
897457
PHARMACOLOGY OF EXTRACT - IN VIVO
CYCLIC AMP PHOSPHODIESTERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
592045
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397357
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
956338
PHARMACOLOGY OF EXTRACT - IN HUMANS
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
56954
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
69534
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
634684
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
694214
PRESENT IN (REVIEW)REVIEW OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
445213
PHARMACOLOGY OF EXTRACT - IN VITRO
PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
693449
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
397377
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394318
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7804
QUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
789067
PHARMACOLOGY OF EXTRACT - IN VITRO
TYROSINASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
628051
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1158213
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ginkgo biloba (GINKGOACEAE)
794715
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTEIN EXPRESSION INHIBITION
Ginkgo biloba (GINKGOACEAE)
76528
PHARMACOLOGY OF COMPOUND - IN VIVO
CONVULSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PYRIDOXINE,4'-METHOXY:
352237
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
43056
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
352226
PHARMACOLOGY OF EXTRACT - IN VIVO
TESTOSTERONE LEVEL DECREASED
Ginkgo biloba (GINKGOACEAE)
397327
CLINICAL STUDIESREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
802578
PHARMACOLOGY OF EXTRACT - IN VITRO
C-JUN-N-TERMINAL KINASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
451023
PHARMACOLOGY OF EXTRACT - IN VIVO
NOREPINEPHRINE LEVELS DECREASED
Ginkgo biloba (GINKGOACEAE)
802533
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
605125
MEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
686225
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Ginkgo biloba (GINKGOACEAE)
391516
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
647123
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIFIBRILLATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
634954
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
550609
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69622
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1290789
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
1301045
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
BILOBOL C-15:1
934840
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280207
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
BENZOIC ACID,3-[5-7-DIHYDROXY-2-(4-METHOXY-PHENYL)-4-OXO-4(H)-CHROMEN-8-YL]-4-METHOXY:
634925
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
501169
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
697923
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACID
629458
IDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINBILOBETIN
874482
CLINICAL STUDIES
VISION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
882170
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
516186
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
686690
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
774913
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
487950
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
874477
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
759274
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
369303
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
396864
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
PHENOL,6-TRIDECYL:
638801
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
922670
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
426275
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYPRENOL 90GINKGO POLYPRENOL 21GINKGO POLYPRENOL 95GINKGO POLYPRENOL 20GINKGO POLYPRENOL 19GINKGO POLYPRENOL 15GINKGO POLYPRENOL 120GINKGO POLYPRENOL 18GINKGO POLYPRENOL 22GINKGO POLYPRENOL 17GINKGO POLYPRENOL 16GINKGO POLYPRENOL 85
394715
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
681965
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1304270
CLINICAL STUDIESREVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
678644
PHARMACOLOGY OF EXTRACT - IN VIVO
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
760074
PLANT REGENERATION FROM CALLUSPLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
69579
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
656829
PHARMACOLOGY OF EXTRACT - IN VITRO
PROLYL ENDOPEPTIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
397388
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
TOXICITY ASSESSMENT(QUANTITATIVE)
Ginkgo biloba (GINKGOACEAE)
1287782
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
361922
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
398099
PHARMACOLOGY OF EXTRACT - IN VITRO
DOPAMINE UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
644552
PHARMACOLOGY OF COMPOUND - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADEC-CIS-10'-ENYL):
634643
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
359435
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
558944
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
354099
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE REDUCTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
397349
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
SEROTONIN (5-HT) AGONIST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
671366
PHARMACOLOGY OF EXTRACT - IN VITRO
OXIDATIVE BURST INHIBITION
Ginkgo biloba (GINKGOACEAE)
804964
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
ESTROGENIC EFFECT
Ginkgo biloba (GINKGOACEAE)
788829
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
397374
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
PROTEIN KINASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
1296811
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
630326
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
TUMOR NECROSING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
673889
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
120389
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYSACCHARIDE GF-2-AGINKGO POLYSACCHARIDE GF-2-BGINKGO POLYSACCHARIDE GF-1GINKGO POLYSACCHARIDE GF-3
870951
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
869167
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLYCOSYL-BETA-1-4-RHAMNOSIDE)
634903
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
956339
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
393660
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
575971
CLINICAL STUDIES
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
497122
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
972748
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
758970
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
CHLOROPHYLLANTHOCYANINSFLAVONOIDS
1178210
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERGLYCEMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
654632
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280218
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
MYRICETIN
7523
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPAPER CHROMATOGRAPHY DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-L-RHAMNO-GLUCOSIDE
1293576
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1178921
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
1178344
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICOAGULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
441209
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
68133
COMPLEMENTARY MEDICINEREVIEW OF
Ginkgo biloba (GINKGOACEAE)
1030435
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
444343
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
715876
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
584457
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIATHEROSCLEROTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
546570
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
69557
CLINICAL STUDIES
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1280775
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIAGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280800
MASS-SPECTRAL FRAGMENTATION REPORTEDAMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGO ANTIFUNGAL PEPTIDE GAFP
789732
PHARMACOLOGY OF EXTRACT - IN VIVO
EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
764250
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONES
45277
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
654628
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
775731
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
1289004
PHARMACOLOGY OF EXTRACT - IN VIVO
SUPEROXIDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
800924
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
487956
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
726000
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPHAGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
644720
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1282812
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
638242
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
VENOUS INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
474920
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(PENTADECYL):SALICYLIC ACID,6-(HEPTADECENYL):SALICYLIC ACID,6-(PENTADEC-CIS-ENYL):LINOLENIC ACIDGINKGOLIC ACID,HYDRO:SALICYLIC ACID,6-(HEPTADECADIENYL):SALICYLIC ACID,6-TRIDECYL:PALMITIC ACIDGINKGOLIC ACID
7421
PRESENT IN (REVIEW)
Ginkgo biloba (GINKGOACEAE)
HEXACOSAN-1-OLBILOBANONEQUERCETIN-3-O-ALPHA-L-RHAMNO-GLUCOSIDELINOLENIC ACIDPINITOLQUERCETINSHIKIMIC ACIDGINKGETIN,ISO:GINKGOLIDE CKAEMPFEROLGINKGOLIDE AOCTACOSAN-1-OLSEQUOYITOLGINKGETINBILOBETINGINKGOLIDE BQUINIC ACIDHEXEN-1-ALASCORBIC ACIDRHAMNETIN,ISO:GINNONEKAEMPFEROL-3-O-ALPHA-L-RHAMNO-GLUCOSIDEDAUCOSTEROLGINNOL
391494
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
623561
PHARMACOLOGY OF EXTRACT - IN VIVO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
639688
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
LDL OXIDATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
710992
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1167892
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394726
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
372044
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
738801
PHARMACOLOGY OF EXTRACT - IN VITRO
LACTATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
395416
STABILITY STUDIES IN PLANT EXTRACTS
Ginkgo biloba (GINKGOACEAE)
1289755
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
564078
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADECA-CIS-9-CIS-12-DIENYL):
697804
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
387860
PHARMACOLOGY OF EXTRACT - IN VIVO
CREATIN KINASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
537426
PHARMACOLOGY OF EXTRACT - IN HUMANS
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
626639
CLINICAL STUDIES
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
485076
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
738798
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
1184833
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
278007
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]-7-O-BETA-D-GLUCOPYRANOSIDE]
673874
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
488739
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTRIGLYCERIDEMIA EFFECT
Ginkgo biloba (GINKGOACEAE)
804280
PHARMACOLOGY OF EXTRACT - IN VITRO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
370931
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
623537
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONE GLYCOSIDES
278022
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
1287245
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
915006
PHARMACOLOGY OF EXTRACT - IN VIVO
MYELOPEROXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
280223
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
1306697
PRESENT IN (REVIEW)
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
1290644
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIATHEROSCLEROTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638808
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN FIBRIL(TYPE I)RETICULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
546576
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
823480
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
741693
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
445500
PHARMACOLOGY OF EXTRACT - IN VIVO
SLEEPING TIME DECREASED
Ginkgo biloba (GINKGOACEAE)
902519
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
874563
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICEREBRAL EDEMA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
396860
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-[PENTADEC-CIS-8'-ENYL]:
89679
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
736484
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(17:2)
1183974
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CARDANOL
363063
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789078
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
788258
PHARMACOLOGY OF EXTRACT - IN VIVO
ADAPTOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1273272
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
804279
PHARMACOLOGY OF EXTRACT - IN VITRO
CASPASE-3 INHIBITION
Ginkgo biloba (GINKGOACEAE)
1183969
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACID
738567
PHARMACOLOGY OF EXTRACT - IN VITRO
VASORELAXATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
765078
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
554489
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:
896488
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
539060
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
681474
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673836
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
639675
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
LDL OXIDATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
686200
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
635028
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
760410
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
68845
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
393945
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-RHAMNOSYL(2''-1'''')-COUMAROYL(7''''-1''''')-GLUCOSIDEQUERCETIN-3-O-RHAMNOSYL(2''-1''')-GLUCOSIDEBILOBALIDEQUERCETINGINKGETIN,ISO:GINKGOLIDE JGINKGOLIDE CKAEMPFEROL-3-O-RHAMNOSYL(2''-1''')-GLUCOSYL(6'''-1'''')-COUMAROYL ESTERKAEMPFEROLGINKGOLIDE AGINKGETINBILOBETINGINKGOLIDE BQUERCETIN-3-O-RHAMNOSYL(2''-1''')-GLUCOSYL(7'''-`1'''')-COUMAR OYL ESTERQUERCETIN-3-O-RHAMNOSYL(2''-1''')-GLUCOSYL(6'''-1''''-COUMAROYL-7-O-BETA-D-GLUCOSIDEKAEMPFEROL-3-O-RHAMNOSYL(2''-1''')-GLUCOSYL(6'''-1'''')-COUMAROYL(7''''-1''''')-GLUCOSIDESCIADOPITYSINRHAMNETIN,ISO:KAEMPFEROL-3-O-RHAMNOSYL(2''-1)-GLUCOSIDE
68004
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
280236
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-RHAMNOGLUCOSIDE
694225
ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROL
767882
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
687283
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
398120
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
927961
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-2-6-DIRHAMNOSYL GLUCOSIDE
1167909
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1288099
PHARMACOLOGY OF EXTRACT - IN HUMANS
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
681440
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1167912
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1285174
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIESTROGENIC EFFECT
Ginkgo biloba (GINKGOACEAE)
280239
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
565443
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
686221
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
TERPENE LACTONES
261133
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
760404
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMARYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
789080
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
673863
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
736483
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(17:1)
979111
IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
LINOLENIC CID
380604
PHARMACOLOGY OF COMPOUND - IN VIVO
ANXIOLYTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
278011
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
870944
PHARMACOLOGY OF EXTRACT - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
394628
CLINICAL STUDIES
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
512156
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
775719
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR SECRETION INHIBITION
Ginkgo biloba (GINKGOACEAE)
786223
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
58494
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1258299
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
734698
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
634998
CLINICAL STUDIES
ANTICOAGULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67481
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
330059
BIOSYNTHESISISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACID
1304393
PRESENT IN (REVIEW)
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
674087
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1198894
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7478
PHARMACOLOGY OF EXTRACT - IN VITRO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1192262
CLINICAL STUDIES
ANTIDEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
359750
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
733433
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
962838
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
394682
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
551294
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
369684
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPARASITIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
277997
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
673849
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
962833
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
686190
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROL
670714
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIARRHYTHMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
371026
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
MEMORY RETENTION IMPAIRMENT
Ginkgo biloba (GINKGOACEAE)
1300838
PHARMACOLOGY OF EXTRACT - IN VIVO
BETA-SECRETASE ENZYME INHIBITION
Ginkgo biloba (GINKGOACEAE)
1202614
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR PROMOTION INHIBITION
Ginkgo biloba (GINKGOACEAE)
369307
PHARMACOLOGY OF EXTRACT - IN VIVO
CORTICOSTEROID SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
278033
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
1297960
PHARMACOLOGY OF EXTRACT - IN VITRO
ARYL HYDROCARBON HYDROXYLASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
1167881
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1312851
CLINICAL STUDIES
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
535714
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGETIN,ISO:RUTINKAEMPFEROL-3-O-2''-6''-DI-O-RHAMNOPYRANOSYL-GLUCOPYRANOSIDEGINKGETINBILOBETINQUERCETIN-3-O-2''-6''-DI-O-RHAMNOPYRANOSYL-GLUCOPYRANOSIDEGINKGOLIDE BSCIADOPITYSIN
69342
CLINICAL STUDIES
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
382608
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
763430
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
AMYOTROPHIC LATERAL SCLEROSIS DISEASE TREATMENT
Ginkgo biloba (GINKGOACEAE)
475636
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
397312
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
695738
PATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
670680
PHARMACOLOGY OF EXTRACT - IN VIVO
RENAL FUNCTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
1007024
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINNOL
673885
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
636671
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
794709
PHARMACOLOGY OF EXTRACT - IN VITRO
LDL OXIDATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
280212
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
69624
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
634972
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
940958
PHARMACOLOGY OF EXTRACT - IN VIVO
BRONCHODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1288825
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394777
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
394871
PHARMACOLOGY OF EXTRACT - IN VIVO
CHOLINERGIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673838
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394335
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
391508
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
552865
PHARMACOLOGY OF EXTRACT - IN VITRO
ATP LEVELS INCREASED
Ginkgo biloba (GINKGOACEAE)
278013
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
823478
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68815
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
710995
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
437906
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
500232
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
397390
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
TERATOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
566576
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Ginkgo biloba (GINKGOACEAE)
391498
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
924079
CLINICAL STUDIES
PLATELET AGGREGATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1184829
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
451017
PHARMACOLOGY OF EXTRACT - IN VIVO
GROWTH HORMONE INHIBITION
Ginkgo biloba (GINKGOACEAE)
535622
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
416765
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
261139
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
397346
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
790559
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
672490
QUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
ABSCISIC ACIDINDOLE-3-ACETIC ACID
280247
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
SYRINGARESINOL-4'-O-BETA-D-GLUCOSIDE
1276179
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
68826
CLINICAL STUDIES
MEMORY RETENTION IMPAIRMENT
Ginkgo biloba (GINKGOACEAE)
387859
PHARMACOLOGY OF EXTRACT - IN VIVO
CARDIOTONIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
713869
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROTEIN
61028
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ginkgo biloba (GINKGOACEAE)
539754
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ARABINITOL,2-CARBOXY:
437905
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
354100
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE FORMATION INDUCTION
Ginkgo biloba (GINKGOACEAE)
1281688
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
902508
PHARMACOLOGY OF EXTRACT - IN VIVO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7807
PMR SPECTRUM REPORTEDQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:
394625
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
731983
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
67075
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
800463
PHARMACOLOGY OF EXTRACT - IN VITRO
HEMEOXYGENASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
7638
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
VERMIFUGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
475633
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
686236
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
652702
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
SEXUAL BEHAVIOR MODIFICATION
Ginkgo biloba (GINKGOACEAE)
803188
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN,2-3-DIHYDRO:
7611
PHARMACOLOGY OF EXTRACT - IN VIVO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167883
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1304083
REVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
280232
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
280221
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONE
802575
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
697930
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CHLOROGENIC ACID
67509
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280208
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
BENZOIC ACID,3-[5-7-DIHYDROXY-2-(4-METHOXY-PHENYL)-4-OXO-4(H)-CHROMEN-8-YL]-4-METHOXY:
487957
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
751818
PHARMACOLOGY OF EXTRACT - IN VIVO
CARDIOEXCITATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
769916
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDSGINKGOLIC ACID,HYDRO:
1290648
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789082
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
398115
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
326989
GC DATA REPORTEDBIOSYNTHESISIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
LINOLENIC ACID,ALPHA:LINOLEIC ACIDOLEIC ACID
397351
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
758736
PHARMACOLOGY OF EXTRACT - IN VIVO
ALANINE AMINOTRANSFERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
394723
CLINICAL STUDIES
ANTIDEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
352629
PHARMACOLOGY OF EXTRACT - IN VIVO
ENDURANCE EFFECT
Ginkgo biloba (GINKGOACEAE)
280210
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
394716
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68563
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Ginkgo biloba (GINKGOACEAE)
1167879
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1281168
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
647089
PHARMACOLOGY OF EXTRACT - IN VIVO
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
647231
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
COUMARIN,ISO: 3-4-DIHYDRO: 8-HYDROXY-3-(6'-PENTADECENYL): 3(R):
1285995
PHARMACOLOGY OF EXTRACT - IN HUMANS
Ginkgo biloba (GINKGOACEAE)
512152
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
410715
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
RESORCYCLIC ACID,6-(PENTADEC-8-ENYL):RESORCYCLIC ACID,6-(TRIDEC-8-ENYL):
669956
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
67735
PHARMACOLOGY OF COMPOUND - IN HUMANSREVIEW OF
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDBILOBOL
704596
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
352230
PHARMACOLOGY OF EXTRACT - IN VIVO
GENE EXPRESSION INDUCTION
Ginkgo biloba (GINKGOACEAE)
759069
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
789083
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
705052
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
CHLOROPHYLLPHEOPHORBIDE APHEOPHORBIDE B
391513
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
676112
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION INHIBITION
Ginkgo biloba (GINKGOACEAE)
426358
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
68973
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTISTRESS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1289021
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
760408
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
395044
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278024
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
RUTIN
942182
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
DOLICHOL
1030432
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE STIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
687276
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
393347
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
394372
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
607642
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1045625
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
800461
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
361927
PHARMACOLOGY OF EXTRACT - IN VIVO
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
750316
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORINBILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE ARUTINRHAMNETIN,ISO: 3-O-RUTINOSIDEGINKGOLIDE B
67590
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1281051
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Ginkgo biloba (GINKGOACEAE)
394954
PHARMACOLOGY OF EXTRACT - IN VIVO
DERMATITIS PRODUCING EFFECT
Ginkgo biloba (GINKGOACEAE)
973495
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
739290
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
424692
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ABSORPTION ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
67970
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
788794
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
626726
PHARMACOLOGY OF EXTRACT - IN VIVO
THROMBUS FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
932387
PHARMACOLOGY OF EXTRACT - IN VITRO
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
477205
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
407011
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
UTERINE STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
BILOBOL
683490
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67734
PHARMACOLOGY OF COMPOUND - IN VIVOREVIEW OF
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDBILOBOL
1275975
PHARMACOLOGY OF COMPOUND - IN VIVO
METABOLISM OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
1276759
CLINICAL STUDIES
THROMBOXANE A2 SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
67615
CLINICAL STUDIES
SUPEROXIDE DISMUTASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1211919
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
617737
PRESENT IN (REVIEW)
Ginkgo biloba (GINKGOACEAE)
CHOLINEBILOBANONEPINITOLBILOBALIDEGINKGOLIC ACID,HYDRO:CATECHOL,EPI-GALLO: (-):QUERCETINGINKGETIN,ISO:CATECHOL,EPI: (-):GINKGOLIDE CCATECHOL,GALLO: (+):KAEMPFEROLGINKGOLIDE ACATECHOL,(+):SEQUOYITOLGINKGETINPRODELPHINIDINBILOBETINGINKGOLIDE BSITOSTEROL,BETA:RHAMNETIN,ISO:
737275
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1289114
CLINICAL STUDIES
BLOOD VISCOSITY DECREASED
Ginkgo biloba (GINKGOACEAE)
352229
PHARMACOLOGY OF EXTRACT - IN VIVO
RNA SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
667191
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
STARCH
6936
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
870948
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-HEPTADECENYL:
758067
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
278019
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-RUTINOSIDE
391506
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
802876
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
67110
PHARMACOLOGY OF EXTRACT - IN HUMANS
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
654657
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAIDENTIFICATION OFPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
673872
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
767801
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
67386
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
889864
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
PROTEIN H(GINKGO BILOBA)LEGUMIN-LIKE PROTEIN(GINKGO BILOBA)
739757
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
673845
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
393884
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1032541
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
705125
PHARMACOLOGY OF EXTRACT - IN VIVO
FREE RADICAL FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
451018
PHARMACOLOGY OF EXTRACT - IN VIVO
ACTH LEVEL DECREASE
Ginkgo biloba (GINKGOACEAE)
726003
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPHAGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
725999
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPHAGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
694591
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
404434
VOUCHER SPECIMEN REPORTED FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1280110
CLINICAL STUDIES
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
444709
PHARMACOLOGY OF EXTRACT - IN VITRO
DOPAMINE UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
763537
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
902517
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ADRENERGIC AGONIST(BETA)
Ginkgo biloba (GINKGOACEAE)
394332
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1289756
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
375577
PHARMACOLOGY OF EXTRACT - IN VIVO
CORTICOSTERONE LEVEL DECREASE
Ginkgo biloba (GINKGOACEAE)
721508
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FORREVIEW OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
396842
CLINICAL STUDIESREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167894
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1323034
PHARMACOLOGY OF EXTRACT - IN VIVO
NOCICEPTIVE RESPONSE REDUCTION
Ginkgo biloba (GINKGOACEAE)
678641
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
636674
PHARMACOLOGY OF EXTRACT - IN VIVO
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
68304
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
MEMBRANE EXPRESSION SUPPRESSION
Ginkgo biloba (GINKGOACEAE)
359742
PHARMACOLOGY OF EXTRACT - IN VIVO
VISION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
370936
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,N-HEPTADECENYL:SALICYLIC ACID,N-HEPTADECYL:SALICYLIC ACID,N-PENTADECENYL:SALICYLIC ACID,N-TRIDECYL:SALICYLIC ACID,N-PENTADECYL:
786222
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
536826
CLINICAL STUDIES
CNS STIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1198893
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
564081
PHARMACOLOGY OF COMPOUND - IN VITRO
GLYCEROL-3-PHOSPHATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADEC-CIS-8-ENYL):
699568
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
738687
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
673834
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
885244
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
634951
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
924078
CLINICAL STUDIES
IMMUNOSTIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1285655
PHARMACOLOGY OF COMPOUND - IN HUMANS
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
637562
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
775281
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOID GLYCOSIDES
95409
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
394621
CLINICAL STUDIES
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
266021
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
TRICETIN-4'-METHYL ETHER-3'-O-BETA-D-GLUCOSIDE
69454
CLINICAL STUDIES
ANTIGLAUCOMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68793
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
635957
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONES(TOTAL)
394679
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
69159
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
134904
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
524770
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGO FLAVONE GLYCOSIDES
261135
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
1192264
CLINICAL STUDIES
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
870959
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
444705
PHARMACOLOGY OF EXTRACT - IN VITRO
SEROTONIN (5-HT) UPTAKE STIMULATION
Ginkgo biloba (GINKGOACEAE)
396857
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-PENTADECYL:
647221
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
1286823
PHARMACOLOGY OF COMPOUND - IN HUMANS
HYPERCHOLESTEROLEMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69054
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
993315
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
885247
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
808388
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
1178922
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697958
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RESORCINOL,5-N-PENTADECYL:BILOBOL
394632
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
676063
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
280243
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-GLUCORHAMNOSIDE
392298
PHARMACOLOGY OF EXTRACT - IN VIVO
RADIOSENSITIZING EFFECT
Ginkgo biloba (GINKGOACEAE)
673853
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
396868
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
RESORCINOL,5-[HEPTADEC-CIS-10'ENYL]:
371230
PHARMACOLOGY OF EXTRACT - IN VITRO
MALONDIALDEHYDE STIMULATION
Ginkgo biloba (GINKGOACEAE)
802872
PHARMACOLOGY OF EXTRACT - IN VIVO
CHOLINE ACETYLTRANSFERASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
697934
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
758738
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTEIN KINASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
69476
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
394727
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
393538
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
721497
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
LEVOPIMARADIENE,SYNTHASE:
505319
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
69263
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
673883
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167891
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
395420
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ZINC
635006
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
396853
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-[HEPTADEC-CIS-10'-ENYL]:
367214
PHARMACOLOGY OF EXTRACT - IN VIVO
BIOAVAILABILITY OF
Ginkgo biloba (GINKGOACEAE)
692052
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
VANILLIC ACIDBILOBALIDEPROTOCATECHUIC ACIDGINKGOLIDE COCTACOSAN-1-OLGINKGOLIDE BTRIACONTANOIC ACIDDAUCOSTEROL
394752
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
882169
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-RUTINOSIDE
788185
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
644625
CLINICAL STUDIES
ERECTILE DYSFUNCTION TREATMENT
Ginkgo biloba (GINKGOACEAE)
1178346
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
769873
PHARMACOLOGY OF EXTRACT - IN VITRO
PHOSPHODIESTERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
628034
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
673877
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
453786
IDENTIFICATION IN BY GLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
695640
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
397362
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
398104
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
68315
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
536609
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
775967
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADEC-10-ENYL):PHENOL,3-(HEPTADECA-CIS-4-7-DIENYL):PHENOL,6-(PENTADEC-8-ENYL):SALICYLIC ACIDPHENOL,3-(PENTADEC-8-ENYL):PHENOL,3-(HEPTADECA-10-ENYL):RESORCINOL,5-(PENTADEC-8-ENYL):
971893
PHARMACOLOGY OF EXTRACT - IN VITRO
OXYGEN RADICAL INHIBITION
Ginkgo biloba (GINKGOACEAE)
789420
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
740981
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
66851
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
571527
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
674934
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
654655
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID IIGINKGOLIC ACID I
395635
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
546188
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
603563
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
PROLACTIN INHIBITION
Ginkgo biloba (GINKGOACEAE)
396527
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
696791
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
803105
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
352225
PHARMACOLOGY OF EXTRACT - IN VIVO
ALDOSTERONE DECREASE
Ginkgo biloba (GINKGOACEAE)
1289006
PHARMACOLOGY OF EXTRACT - IN VIVO
MYELOPEROXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
355841
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
626577
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
394471
PHARMACOLOGY OF EXTRACT - IN VITRO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397358
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1295405
PHARMACOLOGY OF COMPOUND - IN VITRO
MOLLUSCICIDAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(C7:1)
1021832
PHARMACOLOGY OF EXTRACT - IN VITRO
MEMBRANE STABILIZATION EFFECT
Ginkgo biloba (GINKGOACEAE)
1215505
CLINICAL STUDIES
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
635005
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
1288871
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
68544
CLINICAL STUDIESPHARMACOLOGY OF EXTRACT - IN HUMANS
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
56955
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
801342
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
958206
PHARMACOLOGY OF EXTRACT - IN VIVO
ADAPTOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394719
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
782804
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
940960
UV SPECTRUM GIVEN FORIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
391502
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
638243
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1282408
CLINICAL STUDIES
PHARMACOKINETIC ALTERATION
Ginkgo biloba (GINKGOACEAE)
257815
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYSACCHARIDE LGP-1GINKGO POLYSACCHARIDE LGP-2
470771
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
723241
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
705462
PHARMACOLOGY OF EXTRACT - IN VIVO
ANOXIA TOLERANCE INCREASED
Ginkgo biloba (GINKGOACEAE)
791534
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
CYCLOOXYGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
970924
PLANT TISSUE CULTURE MARKER CODEMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
280237
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-RHAMNOGLUCOSIDE
671402
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN KINASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
697927
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
COUMARIC ACID,PARA:
1192260
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
794711
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERTRIGLYCERIDEMIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68100
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
TAURINE
66937
CLINICAL STUDIES
HYPOTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1176929
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
DESMUTAGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673841
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1301050
PHARMACOLOGY OF COMPOUND - IN VITRO
HIV PROTEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
CARDANOL C-15:1CARDANOL C-15:0CARDANOL C-17:1CARDANOL C-13:0
927964
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-[6'''-O-PARA-COUMAROYL-BETA-D-GLUCOSYL-(1-2)-ALPHA-L-RHAMNOSIDE]
1303682
REVIEW OF
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
424847
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
HEPTACOSANE,N:
356080
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FORBIOLOGICAL TRANSFORMATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
7424
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CATECHIN,(+):CATECHIN,EPI: (-):GALLOCATECHIN,(+):CATECHIN,EPI-GALLO: (-):
782217
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Ginkgo biloba (GINKGOACEAE)
803743
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
765085
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
949707
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
667762
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
626648
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
397386
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
495534
PHARMACOLOGY OF EXTRACT - IN VITRO
CHLORIDE CHANNEL INHIBITION
Ginkgo biloba (GINKGOACEAE)
521829
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
683185
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
882168
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA(1-4)-RHAMNOSIDE)
564075
PHARMACOLOGY OF COMPOUND - IN VITRO
GLYCEROL-3-PHOSPHATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-TRIDECYL:
917460
PHARMACOLOGY OF EXTRACT - IN HUMANS
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
409319
BIOSYNTHESISIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACID
700432
PHARMACOLOGY OF EXTRACT - IN VITRO
HEMEOXYGENASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
695675
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
636678
PHARMACOLOGY OF EXTRACT - IN VIVO
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
700512
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1276180
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTICOAGULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394626
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
623564
CRUDE DRUG DESCRIPTION
Ginkgo biloba (GINKGOACEAE)
639681
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
47853
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
738683
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
1178340
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
68061
CLINICAL STUDIES
ANTIHYPOGLYCEMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167880
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397379
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
697475
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
CHLOROPHYLLCAROTENOIDS
624005
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONE GLYCOSIDES
536703
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
695494
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
397321
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
674969
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
697865
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERACTIVITY INHIBITION
Ginkgo biloba (GINKGOACEAE)
721502
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
678975
MASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROLRHAMNETIN,ISO:
394774
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
331775
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
476764
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
PYRIDOXINE,4-O-METHYL:
421124
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROEXCITATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
610871
PLANT TISSUE CULTURE MARKER CODEIN VITRO CULTURE CONDITIONS DESCRIBED
Ginkgo biloba (GINKGOACEAE)
738694
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697916
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACIDPROTOCATECHUIC ACIDFERULIC ACIDCOUMARIC ACID,PARA:CHLOROGENIC ACID
589633
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1323037
PHARMACOLOGY OF EXTRACT - IN VIVO
NOCICEPTIVE RESPONSE REDUCTION
Ginkgo biloba (GINKGOACEAE)
421537
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
956337
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
66641
CLINICAL STUDIES
MONOAMINE OXIDASE INHIBITION(TYPE A)
Ginkgo biloba (GINKGOACEAE)
674970
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
697943
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
POLYPRENOLS
681044
PHARMACOLOGY OF EXTRACT - IN VIVO
GENE EXPRESSION INDUCTION
Ginkgo biloba (GINKGOACEAE)
902522
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
CAPILLARY PERMEABILITY DECREASED
Ginkgo biloba (GINKGOACEAE)
67025
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
670698
PHARMACOLOGY OF EXTRACT - IN VIVO
MONOAMINE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
68666
CLINICAL STUDIES
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
714653
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
788792
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
964581
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-RHAMNOSYL(1-2)RHAMNOSYL(1-6)GLUCOSIDEQUERCITRINNICOTIFLORINASTRAGALINQUERCITRIN,ISO:KAEMPFEROL-3-O-(6'''-PARA-COUMAROYL-GLUCOSYL(1-2)RHAMNOSIDE)QUERCETIN-3-O-(6'''-PARA-COUMAROYL-GLUCOSYL(1-2)RHAMNOSIDE)RUTINRHAMNETIN,ISO: 3-O-RUTINOSIDEQUERCETIN-3-O-RHAMNOSYL(1-2)RHAMNOSYL(1-6)GLUCOSIDE
394336
PHARMACOLOGY OF EXTRACT - IN HUMANS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1275302
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACIDSGINKGOLIC ACIDSURUSHIOLSCARDANOLS
397369
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1158212
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ginkgo biloba (GINKGOACEAE)
743325
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
352236
PHARMACOLOGY OF COMPOUND - IN VIVO
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
1167906
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68302
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR LOSS INHIBITION
Ginkgo biloba (GINKGOACEAE)
401454
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
681045
PHARMACOLOGY OF EXTRACT - IN VIVO
CYTOCHROME P450 STIMULATION
Ginkgo biloba (GINKGOACEAE)
871588
PHARMACOLOGY OF EXTRACT - IN VIVO
CHOLERETIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
684433
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
1311437
MEDICINAL FOLKLORE REPORTED FOR
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
699565
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
605122
MEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
316712
MEDICINAL FOLKLORE REPORTED FOR
EYE PROBLEMS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
803981
PHARMACOLOGY OF EXTRACT - IN VITRO
NADH DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
1289007
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
551297
PHARMACOLOGY OF EXTRACT - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Ginkgo biloba (GINKGOACEAE)
926162
PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
765080
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
934841
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
280248
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
LUTEOLIN-3'-O-BETA-D-GLUCOSIDE
670653
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673862
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397370
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIARRHYTHMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697924
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACID
383691
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
710993
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
775518
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
COLCHICINE
697805
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMALARIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
932386
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
474921
IDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADECENYL):SALICYLIC ACID,6-(PENTADEC-CIS-ENYL):LINOLENIC ACIDSALICYLIC ACID,6-TRIDECYL:PALMITIC ACIDGINKGOLIC ACID,DIHYDRO:GINKGOLIC ACIDBILOBOL
760400
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
636862
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1156594
ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR
ABORTIFACIENT EFFECT
Ginkgo biloba (GINKGOACEAE)
397383
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
638802
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN FIBRIL(TYPE I)RETICULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
965667
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
676066
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
693389
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
789814
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
673873
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67497
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1258301
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
446029
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE B
68579
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
396526
PHARMACOLOGY OF EXTRACT - IN VIVO
VISION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
940979
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
394683
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1183973
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
BILOBOL
715880
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-UNDECYL:OCTADECA-9-12-DIEN-1-ALEICOSANE,N:OCTADECAN-1-AL
788771
PHARMACOLOGY OF EXTRACT - IN VITRO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
1287561
PHARMACOLOGY OF COMPOUND - IN VITRO
ELECTROPHYSIOLOGICAL EFFECTS
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE AGINKGOLIDE B
652708
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
354101
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
803162
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
760398
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
89680
CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
802830
PHARMACOLOGY OF EXTRACT - IN VIVO
ANXIOLYTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
395423
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
IRON
445501
PHARMACOLOGY OF COMPOUND - IN VIVO
SLEEPING TIME DECREASED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
717082
PHARMACOLOGY OF EXTRACT - IN VIVO
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
796670
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
56951
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE MGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
396863
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PHENOL,6-TRIDECYL:
885250
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
399338
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
316717
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
66642
CLINICAL STUDIES
MONOAMINE OXIDASE INHIBITION(TYPE B)
Ginkgo biloba (GINKGOACEAE)
758241
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
TERPENE LACTONES
445212
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
397131
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278027
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
803970
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
502221
HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKOGLIDE CBILOBALIDEGINKGOLIDE AGINKGOLIDE B
927965
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-[6'''-O-PARA-COUMAROYL-BETA-D-GLUCOSYL-(1-2)-ALPHA-L-RHAMNOSIDE]
789644
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
68126
CLINICAL STUDIES
HEARING IMPROVEMENT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1175442
CLINICAL STUDIES
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
630292
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
GINKGO FLAVONOID I
783534
PHARMACOLOGY OF EXTRACT - IN VITRO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
628050
CLINICAL STUDIES
CNS DEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
372047
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
ATP LEVELS DECREASED
Ginkgo biloba (GINKGOACEAE)
1289005
PHARMACOLOGY OF EXTRACT - IN VIVO
XANTHINE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
396760
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
45276
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
607639
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
419235
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
AIDS THERAPEUTIC EFFECTS
Ginkgo biloba (GINKGOACEAE)
395636
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTICONVULSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
388338
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
789421
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
823477
PHARMACOLOGY OF EXTRACT - IN VITRO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
915004
PHARMACOLOGY OF EXTRACT - IN VIVO
ACETYLGLUCOSEAMINIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
971892
PHARMACOLOGY OF EXTRACT - IN VIVO
MUSCARINIC RECEPTOR INCREASE
Ginkgo biloba (GINKGOACEAE)
68127
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
352632
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
962837
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(6'''-O-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)ALPHA-L-RHAMNOPYRANOSIDE
628032
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
635086
CLINICAL STUDIES
ANTI-OCCLUSIVE ARTERIAL DISEASE
Ginkgo biloba (GINKGOACEAE)
654656
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
765081
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
391495
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
634922
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
416764
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
762899
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
398117
CLINICAL STUDIESREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1049320
IDENTIFICATION IN BY GLC AFTER SAPONIFICATION
Ginkgo biloba (GINKGOACEAE)
CAMPESTEROLSITOSTEROL,BETA:
1283535
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
266018
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
LUTEOLIN-3'-O-BETA-D-GLUCOSIDE
783664
PHARMACOLOGY OF EXTRACT - IN VITRO
TRANSCRIPTION STIMULATION
Ginkgo biloba (GINKGOACEAE)
361930
PHARMACOLOGY OF EXTRACT - IN VIVO
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
670628
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
564079
PHARMACOLOGY OF COMPOUND - IN VITRO
GLYCEROL-3-PHOSPHATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADECA-CIS-9-CIS-12-DIENYL):
760405
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMARYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
444706
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) UPTAKE STIMULATION
Ginkgo biloba (GINKGOACEAE)
425635
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
1167901
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394629
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
679011
COMPLEMENTARY MEDICINEREVIEW OF
Ginkgo biloba (GINKGOACEAE)
1167873
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
399300
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAPATENT DESCRIBEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
922667
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
940980
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
788788
PHARMACOLOGY OF EXTRACT - IN VIVO
NEURITOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1295404
PHARMACOLOGY OF COMPOUND - IN VITRO
MOLLUSCICIDAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID (C15:1)GINKGOLIC ACID (C13:0)
278008
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]-7-O-BETA-D-GLUCOPYRANOSIDE]
397310
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278021
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-RUTINOSIDE
445502
PHARMACOLOGY OF COMPOUND - IN VIVO
SLEEPING TIME DECREASED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
1193219
PHARMACOLOGY OF COMPOUND - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
278016
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNPYRANOSIDE
1209520
PHARMACOLOGY OF EXTRACT - IN HUMANS
MICROSOMAL METABOLIZING SYSTEM INDUCTION
Ginkgo biloba (GINKGOACEAE)
788802
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISTRESS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
794710
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
823481
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673888
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
382607
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
635032
REVIEW OF
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1184832
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
667154
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
897458
PHARMACOLOGY OF EXTRACT - IN VIVO
CYCLIC AMP PHOSPHODIESTERASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
394738
PHARMACOLOGY OF EXTRACT - IN VITRO
MEMBRANE STABILIZATION EFFECT
Ginkgo biloba (GINKGOACEAE)
354702
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
475637
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-RUTINOSIDE
397373
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
870956
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)
359436
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1296751
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1179456
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
25213
ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR
LABOR INDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
779273
PHARMACOLOGY OF EXTRACT - IN VITRO
PROLYL ENDOPEPTIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
782216
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1007025
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
APIGENIN
807170
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
634683
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1281276
CLINICAL STUDIES
ANTIMULTIPLE SCLEROSIS EFFECT
Ginkgo biloba (GINKGOACEAE)
686213
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONE GLYCOSIDES
806997
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MIGRATION EFFECT
Ginkgo biloba (GINKGOACEAE)
394369
CLINICAL STUDIES
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
380603
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
684432
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
767628
PHARMACEUTICAL FORMULATION OF A PLANT
Ginkgo biloba (GINKGOACEAE)
674968
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
398106
CLINICAL STUDIESREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
729484
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
45311
UV SPECTRUM GIVEN FORPAPER CHROMATOGRAPHY DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLRHAMNETIN,ISO:
715877
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
565442
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE A
678971
PHARMACOLOGY OF EXTRACT - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Ginkgo biloba (GINKGOACEAE)
870444
PHARMACOLOGY OF EXTRACT - IN HUMANS
GLUCOSE UTILIZATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
760411
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
511009
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
355753
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
783052
SYNTHESIS OF ANALOGSISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE MGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1280776
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIAGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7741
PHARMACOLOGY OF EXTRACT - IN VITRO
ISOCITRATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
979110
IDENTIFICATION IN BY GLC AFTER SAPONIFICATION
Ginkgo biloba (GINKGOACEAE)
LINOLENIC ACIDPALMITIC ACID
1301044
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
CARDANOL C-15:0
551293
MEDICINAL FOLKLORE REPORTED FOR
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
743350
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
393878
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673866
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
391517
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
737231
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
682209
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
697920
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
396867
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RESORCINOL,5-[HEPTADEC-CIS-10'ENYL]:
789133
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
POLYSACHARIDE GBSP
766346
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
ACTIN
979108
IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
OLEIC ACID
396530
PHARMACOLOGY OF EXTRACT - IN VIVO
BIOAVAILABILITY OF
Ginkgo biloba (GINKGOACEAE)
798298
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
475634
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-2-6-DIRHAMNOSYL-GLUCOSIDE
634240
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
652703
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
DERMATITIS PRODUCING EFFECT
Ginkgo biloba (GINKGOACEAE)
397347
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
SEROTONIN (5-HT) AGONIST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1301049
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
ALKYLSALICYLIC ACID C-15:0
1298633
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
802931
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1282995
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
278032
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
670713
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIARRHYTHMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673848
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
956150
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
900775
PHARMACOLOGY OF EXTRACT - IN VIVO
ALDEHYDE DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
1288936
PHARMACOLOGY OF EXTRACT - IN VIVO
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
678640
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
1300835
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167884
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
407015
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOIC ACIDGINNOL
801343
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
874517
CLINICAL STUDIES
ANTIVERTIGO EFFECT
Ginkgo biloba (GINKGOACEAE)
352628
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Ginkgo biloba (GINKGOACEAE)
874486
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
361923
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
394680
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
758692
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
682505
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
67863
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
681475
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIARRHYTHMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
972747
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
280219
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
TAMARIXETIN
68898
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
526080
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
896489
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
546571
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIEMETIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
915000
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
762462
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
946093
IDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
759278
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
404003
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397322
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
676067
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1183004
PHARMACOLOGY OF EXTRACT - IN VIVO
RECEPTOR BINDING(DOPAMINE) DECREASED
Ginkgo biloba (GINKGOACEAE)
1260730
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
944934
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE AGINKGOLIDE BGINGOLIDE C
654627
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167911
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
758684
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
639678
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
736482
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(15:1)
391499
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
261134
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
957252
IDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
509780
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
1007029
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PINITOL,(+):
278010
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
385126
PHARMACOLOGY OF EXTRACT - IN VITRO
TYROSINASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
537425
PHARMACOLOGY OF EXTRACT - IN HUMANS
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1294132
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
488735
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
8853
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1275122
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
788828
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE-S-TRANSFERASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
759273
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTECTIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
924080
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
394380
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1192261
CLINICAL STUDIES
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
426794
PRODUCT DEVELOPMENT OF HERBAL EXTRACTPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
1281045
CLINICAL STUDIES
ANTINAUSEANT EFFECT
Ginkgo biloba (GINKGOACEAE)
1276498
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
870945
PHARMACOLOGY OF EXTRACT - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
370932
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1277750
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
511744
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTISTRESS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
760416
PHARMACOLOGY OF EXTRACT - IN VIVO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
1198897
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
655129
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
656828
PHARMACOLOGY OF EXTRACT - IN VITRO
PROLYL ENDOPEPTIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
638807
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
68003
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1301653
CLINICAL STUDIES
ANXIOLYTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
371025
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANXIOLYTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
394734
CLINICAL STUDIES
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
652705
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
713408
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1306698
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIMIGRAINE EFFECT
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
655589
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFPATENT DESCRIBEDQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONONE GLYCOSIDESGINKGOLIDE CGINKGOLIDE AGINKGOLIDE BGINKGOLIC ACID
369257
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
769899
DEPARTMENTAL MARKER CODE. NO DATA CODED
Ginkgo biloba (GINKGOACEAE)
1277579
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
445506
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
354677
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIPLATELET ACTIVITY
Ginkgo biloba (GINKGOACEAE)
644551
PHARMACOLOGY OF COMPOUND - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(PENTADEC-CIS-8'-ENYL)
68974
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
802576
PHARMACOLOGY OF EXTRACT - IN VITRO
T-CELL ACTIVATION MARKER(CD25) EXPRESSION INHIBITION
Ginkgo biloba (GINKGOACEAE)
684404
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673884
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
765088
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
673880
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
393661
PHARMACOLOGY OF EXTRACT - IN HUMANS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1179452
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
69058
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
670681
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
397311
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTISPASMOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
870952
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
396852
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-[PENTADEC-CIS-8'-ENYL]:
729518
HERBAL INTERACTIONS
Ginkgo biloba (GINKGOACEAE)
885243
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
554488
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
518708
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
CHOLESTEROL LEVEL DECREASE
Ginkgo biloba (GINKGOACEAE)
388605
PHARMACOLOGY OF EXTRACT - IN HUMANS
METABOLISM OF
Ginkgo biloba (GINKGOACEAE)
766442
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO:
704595
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN EXPRESSION INHIBITION
Ginkgo biloba (GINKGOACEAE)
394788
CLINICAL STUDIES
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
719477
PHARMACOLOGY OF EXTRACT - IN VIVO
CATALASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
451022
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
824136
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
739823
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
591779
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
394735
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
763432
IDENTIFICATION IN BY HPLCQUANTITATIVE DATAPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
678974
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
394373
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
678977
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
395634
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
FLAVONOID GLYCOSIDES
962840
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-RUTINOSIDE
635956
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLRHAMNETIN,ISO:
357573
PHARMACOLOGY OF EXTRACT - IN VITRO
VASOCONSTRICTION INHIBITION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
787937
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
LIPOXYGENASE ISOZYMES
495843
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET ACTIVATING FACTOR BINDING INHIBITION
Ginkgo biloba (GINKGOACEAE)
972746
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
6935
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
718859
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
669950
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
261136
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
752895
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67662
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1258575
TOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR
DERMATITIS PRODUCING EFFECT
Ginkgo biloba (GINKGOACEAE)
134903
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-[2''-O-6'''-O-{PARA-(7''''-O-BETA-D-GLUCOPYRANOSYL)-COUMAROYL}-BETA-D-GLUCOPYRANOSYL]-ALPHA-L-RHAMNOPYRANOSIDE
714737
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
782805
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
674971
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
1276758
CLINICAL STUDIES
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
635074
CLINICAL STUDIES
BLOOD VISCOSITY DECREASED
Ginkgo biloba (GINKGOACEAE)
396858
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-PENTADECYL:
788769
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
623562
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
885246
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
POPULNIN
523239
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1293455
VOUCHER SPECIMEN REPORTED FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
391507
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
1178923
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
681925
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
870947
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-PENTADECENYL:
394791
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
765086
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
416767
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
743395
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
VANILLIC ACIDBENZOIC ACID,4-HYDROXY:HIPPURIC ACID,4-HYDROXY:PROTOCATECHUIC ACIDPHENYLACETIC ACID,3-HYDROXY:VANILLIC ACID,HOMO:PROPIONIC ACID,3-(4-HYDROXY-PHENYL):PHENYLACETIC ACID,3-4-DIHYDROXY:PROPIONIC ACID,3-(3-HYDROXY-PHENYL):HIPPURIC ACID,4-HYDROXY: 3-METHOXY:
396869
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GREVILLOL
69160
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
68633
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIFATIGUE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
782218
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
369308
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTEIN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
654626
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1284943
CLINICAL STUDIES
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
1287560
PHARMACOLOGY OF EXTRACT - IN VITRO
ELECTROPHYSIOLOGICAL EFFECTS
Ginkgo biloba (GINKGOACEAE)
803742
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
625990
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
397385
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
554490
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
758737
PHARMACOLOGY OF EXTRACT - IN VIVO
ASPARTATE AMINOTRANSFERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
803187
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN,2-3-DIHYDRO:
475639
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-COUMAROYL-GLUCORHAMNOSIDE
451015
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
809670
PHARMACOLOGY OF EXTRACT - IN VITRO
UREASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
652700
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
724078
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1277580
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
644624
PHARMACOLOGY OF EXTRACT - IN HUMANS
ERECTILE DYSFUNCTION TREATMENT
Ginkgo biloba (GINKGOACEAE)
470770
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
134906
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-[2''-O-6'''-O-PARA-COUMAROYL)-BETA-D-GLUCOPYRANOSYL]-ALPHA-L-RHAMNOPYRANOSYL-7-O-BETA-D-GLUCOPYRANSOIDE
76525
PHARMACOLOGY OF EXTRACT - IN VIVO
CONVULSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
639684
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
700474
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1323035
PHARMACOLOGY OF EXTRACT - IN VIVO
NOCICEPTIVE RESPONSE REDUCTION
Ginkgo biloba (GINKGOACEAE)
629457
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
280213
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
APIGENIN
598544
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
704597
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN EXPRESSION INHIBITION
Ginkgo biloba (GINKGOACEAE)
652707
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
445505
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
673859
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
837803
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
813182
IDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
CATECHIN,(+):
639689
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MYOCARDIAL ISCHEMIC IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
607641
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
901484
PHARMACOLOGY OF EXTRACT - IN VIVO
DERMATITIS PRODUCING EFFECT
Ginkgo biloba (GINKGOACEAE)
1045624
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68305
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
GLUCOCORTICOID RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
497119
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
788793
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1298645
CLINICAL STUDIES
BLOOD VISCOSITY DECREASED
Ginkgo biloba (GINKGOACEAE)
739292
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
397355
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
278009
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]-7-O-BETA-D-GLUCOPYRANOSIDE]
67733
PHARMACOLOGY OF COMPOUND - IN VIVOREVIEW OF
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDBILOBOLGINKGOL
654616
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
897282
PHARMACOLOGY OF EXTRACT - IN VITRO
ENZYME EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
755439
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
565441
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
973483
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
524615
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICLASTOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
352228
PHARMACOLOGY OF EXTRACT - IN VIVO
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
Ginkgo biloba (GINKGOACEAE)
394631
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
760412
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
397343
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
767802
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
758066
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
80835
UV SPECTRUM GIVEN FORGEL PERMEATION CHROMATOGRAPHY USEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECHEMICAL IONIZATION MASS SPECTRUM REPORTED
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
397366
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
SEROTONIN (5-HT) LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
723242
PHARMACOLOGY OF EXTRACT - IN VIVO
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
802539
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CHLOROPHYLL
352235
PHARMACOLOGY OF COMPOUND - IN VIVO
ACTH LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
394792
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
902516
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
PHOSPHODIESTERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
346830
CLINICAL STUDIES
THIOBARBITURATE REACTING SUBSTANCE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1323892
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
489829
PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
1183975
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CARDANOL
398105
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
67087
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1032542
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACIDS
280224
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
681226
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID,HYDRO:GINKGOLINIC ACID,HYDRO:GINKGOLIC ACIDGINKGONEOLIC ACID
673865
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
695639
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
902515
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
396856
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-TRIDECYL:
673846
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
737232
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
623541
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
683118
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
LIGNIN
789423
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
7524
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAPAPER CHROMATOGRAPHY DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
488736
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
626576
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
441211
PHARMACOLOGY OF EXTRACT - IN HUMANS
CHRONOTROPIC EFFECT NEGATIVE
Ginkgo biloba (GINKGOACEAE)
1296754
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1183968
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
774844
VOUCHER SPECIMEN REPORTED FORPCR ANALYSIS(PLANT)
Ginkgo biloba (GINKGOACEAE)
786221
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
654615
PHARMACOLOGY OF EXTRACT - IN VITRO
RNA SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
69461
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
642208
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROGEN PEROXIDE SCAVENGER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397361
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
644657
CLINICAL STUDIES
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
874840
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICEREBRAL EDEMA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
391514
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
634952
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
760686
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
COLCHICINE
1000531
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
695491
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
760407
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMARYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
394620
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
870953
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
693386
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
599855
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
375819
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
687275
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
69165
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
835991
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESHPLC DATA REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDTLC DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
915007
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1323151
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638803
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
359437
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
493100
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICEREBRAL EDEMA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673887
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
68352
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
605827
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67145
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
758242
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS(TOTAL)
954786
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:
67043
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
750175
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(13:0)GINKGOLIC ACID(15:1)GINKGOLIC ACID(15:0)GINKGOLIC ACID(17:1)
667761
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
590948
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GALACTOCEREBROSIDE
1294134
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
993314
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS 50-100 MGM
Ginkgo biloba (GINKGOACEAE)
MYRICETIN,3'-O-METHYL-H: 3-O-ALPHA-L-RHAMNOSIDE
391503
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
470772
PHARMACOLOGY OF EXTRACT - IN VIVO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
743326
IDENTIFICATION IN BY GLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
760171
GC DATA REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGY
Ginkgo biloba (GINKGOACEAE)
715878
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
520155
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
699564
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
891972
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-(ALPHA-RHAMNOSYL(1-2)ALPHA-RHAMNOSYL(1-6)BETA-D-GLUCSOIDE
1324688
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
CYTOPROTECTIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
TAURINE
362496
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
391496
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
1301051
PHARMACOLOGY OF COMPOUND - IN VITRO
HIV PROTEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
BILOBOL C-15:1
371233
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE DISMUTASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
802574
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERFERON-GAMMA SECRETION INHIBITION
Ginkgo biloba (GINKGOACEAE)
370930
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROXIDE RADICAL GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
393565
PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
697933
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
726002
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPHAGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7423
PAPER CHROMATOGRAPHY DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
397350
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
767953
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
924077
CLINICAL STUDIES
BLOOD VISCOSITY INCREASED
Ginkgo biloba (GINKGOACEAE)
451019
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
PROLACTIN INHIBITION
Ginkgo biloba (GINKGOACEAE)
1167890
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
643143
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
DOLICHOLS
370228
PHARMACOLOGY OF EXTRACT - IN VIVO
LEARNING ENHANCEMENT
Ginkgo biloba (GINKGOACEAE)
444708
PHARMACOLOGY OF EXTRACT - IN VITRO
SEROTONIN (5-HT) UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
682520
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ginkgo biloba (GINKGOACEAE)
316716
MEDICINAL FOLKLORE REPORTED FOR
ANTIVERTIGO EFFECT
Ginkgo biloba (GINKGOACEAE)
673876
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
759049
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
634241
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE HBGINKGOLIDE A
1007030
QUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SEQUOYITOL
363475
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLGINKGETINBILOBETINSCIADOPITYSINRHAMNETIN,ISO:
708955
IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GLUCOSEXYLOSEGALACTOSEMANNOSERHAMNOSE
68861
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
638796
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
491823
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
757263
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1211920
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
1030436
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397365
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
SEROTONIN (5-HT) LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
397344
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1289640
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394367
PHARMACOLOGY OF EXTRACT - IN HUMANS
PREMENSTRUAL SYNDROME TREATMENT
Ginkgo biloba (GINKGOACEAE)
763369
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
623901
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
788831
PHARMACOLOGY OF EXTRACT - IN VIVO
PENTOXYRESORUFIN-O-DEALKYLASE(PROD) STIMULATION
Ginkgo biloba (GINKGOACEAE)
971760
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
421125
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROEXCITATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
393857
ISOLATION AND IDENTIFICATION OFREVIEW OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDBILOBOLGINKGOL
280909
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE LGINKGOLIDE K
775282
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
476765
PHARMACOLOGY OF COMPOUND - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
PYRIDOXINE,4-O-METHYL:
68734
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
BIOAVAILABILITY OF
Ginkgo biloba (GINKGOACEAE)
352231
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
800462
PHARMACOLOGY OF EXTRACT - IN VITRO
CASPASE-3 INHIBITION
Ginkgo biloba (GINKGOACEAE)
639685
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
804408
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
69425
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
396528
STABILITY STUDIES IN PLANT EXTRACTS
Ginkgo biloba (GINKGOACEAE)
1289615
PHARMACOLOGY OF EXTRACT - IN VIVO
PULMONARY EDEMA PROTECTION
Ginkgo biloba (GINKGOACEAE)
504826
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697919
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
763025
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
352224
PHARMACOLOGY OF EXTRACT - IN VIVO
CORTICOSTERONE LEVEL DECREASE
Ginkgo biloba (GINKGOACEAE)
69158
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
870440
PHARMACOLOGY OF EXTRACT - IN HUMANS
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
385963
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE TRANSPORT STIMULATION
Ginkgo biloba (GINKGOACEAE)
565665
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCORRECTION OF STRUCTUREISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)
355842
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
394785
PHARMACOLOGY OF EXTRACT - IN VITRO
MEMBRANE FLUIDITY INCREASED
Ginkgo biloba (GINKGOACEAE)
626298
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7806
PMR SPECTRUM REPORTEDQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
280910
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
635004
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
394754
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
676064
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
630291
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGO FLAVONOID I
605128
MEDICINAL FOLKLORE REPORTED FOR
ANTITUSSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
695042
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280242
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-GLUCORHAMNOSIDE
1304069
CLINICAL STUDIESREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
355878
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
687282
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET ACTIVATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
887729
IDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
NEOXANTHIN,TRANS:VIOLAXANTHIN,TRANS:LUTEINNEOXANTHIN,CIS:CAROTENE,BETA:CAROTENE,GAMMA:ZEAXANTHINFLAVOXANTHINCAROTENE,ALPHA:VIOLAXANTHIN,CIS:LUTEIN,5-6-EPOXY:AUROXANTHIN
549072
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
683184
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
501167
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
551296
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET ACTIVATING FACTOR BINDING INHIBITION
Ginkgo biloba (GINKGOACEAE)
66936
CLINICAL STUDIES
INSULIN LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
634923
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
517583
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
356081
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FORBIOLOGICAL TRANSFORMATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
489065
PHARMACOLOGY OF EXTRACT - IN VITRO
OXYGEN CONSUMPTION DECREASE
Ginkgo biloba (GINKGOACEAE)
404393
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDES
638810
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN FIBRIL(TYPE I)RETICULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
927963
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
788827
PHARMACOLOGY OF EXTRACT - IN VIVO
CYTOCHROME P450 LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
69623
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
714213
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
LYSINEGLUCOSEMYRISTIC ACIDSTEARIC ACIDFRUCTOSESTARCHLEUCINE,ISO:PALMITIC ACIDASPARTIC ACIDGLUTAMIC ACIDLINOLEIC ACIDALANINEOLEIC ACIDARGININEHISTIDIN
280209
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
769874
PHARMACOLOGY OF EXTRACT - IN VITRO
CALCIUM LEVEL DECREASE(INTRACELLULAR)
Ginkgo biloba (GINKGOACEAE)
1297152
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIESREVIEW OF
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
1301055
PHARMACOLOGY OF EXTRACT - IN VITRO
HIV PROTEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
ALKYLSALICYLIC ACID C-15:0
758990
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
609665
PHARMACOLOGY OF EXTRACT - IN VIVO
ANXIETY INDUCTION
Ginkgo biloba (GINKGOACEAE)
538258
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE AGINKGOLIDE B
443699
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
261131
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
686228
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
280231
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
979113
IDENTIFICATION IN BY GLC AFTER SAPONIFICATION
Ginkgo biloba (GINKGOACEAE)
LINOLEIC ACIDOLEIC ACID
69076
PHARMACOLOGY OF EXTRACT - IN HUMANS
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
626649
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROXIDE RADICAL GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
654630
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789418
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
397354
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
623565
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
APIGENIN
687253
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
280804
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGO ANTIFUNGAL PEPTIDE GAFP
1295403
PHARMACOLOGY OF EXTRACT - IN VITRO
MOLLUSCICIDAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
804278
PHARMACOLOGY OF EXTRACT - IN VITRO
AMYLOID-BETA AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
788184
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
678642
PHARMACOLOGY OF EXTRACT - IN VIVO
LEARNING ENHANCEMENT
Ginkgo biloba (GINKGOACEAE)
1178347
PHARMACOLOGY OF EXTRACT - IN VIVO
CONDITIONED AVOIDANCE RESPONSE INCREASED
Ginkgo biloba (GINKGOACEAE)
1283548
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
443701
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROEXCITATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
401479
CLINICAL STUDIES
PREMENSTRUAL SYNDROME TREATMENT
Ginkgo biloba (GINKGOACEAE)
391510
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
708183
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
DNA
626655
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACIDVANILLIC ACIDBENZOIC ACID,4-HYDROXY:VANILLIC ACID,ISO:PROTOCATECHUIC ACIDFERULIC ACIDCOUMARIC ACID,PARA:SINAPIC ACID
398118
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1298194
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
740980
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
634955
CLINICAL STUDIES
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
1301048
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
ALKYLSALICYLIC ACID C-17:1
972909
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
739284
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE AGINKGOLIDE B
1293281
PHARMACOLOGY OF EXTRACT - IN VIVO
APOPTOSIS INDUCTION
Ginkgo biloba (GINKGOACEAE)
370929
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROXIDE RADICAL GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
394775
CLINICAL STUDIESREVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
395424
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1030433
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
421536
PHARMACOLOGY OF EXTRACT - IN VITRO
FATTY ACID OXIDATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
349387
PHARMACOLOGY OF EXTRACT - IN VIVO
GLYCOGEN CONTENT INCREASED
Ginkgo biloba (GINKGOACEAE)
370218
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
766443
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
475638
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-COUMAROYL-GLUCORHAMNOSIDE
676065
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
497118
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
261130
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
1179455
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
805040
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTISTRESS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
366464
PHARMACOLOGY OF EXTRACT - IN VIVO
DOPAMINE METABOLISM ALTERATION
Ginkgo biloba (GINKGOACEAE)
874485
CLINICAL STUDIES
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
280227
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
678981
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO:
361924
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
67827
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS
ATTENTION DEFICIT IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
68828
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MEMORY RETENTION IMPAIRMENT
Ginkgo biloba (GINKGOACEAE)
1284938
CLINICAL STUDIESREVIEW OF
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1007026
QUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
COUMARIC ACID,PARA:
47541
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
LINOLENIC ACIDHEX-TRANS-2-EN-1-AL
68540
PHARMACOLOGY OF EXTRACT - IN HUMANS
CONVULSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
634970
PHARMACOLOGY OF EXTRACT - IN VIVO
BIOAVAILABILITY OF
Ginkgo biloba (GINKGOACEAE)
590949
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
488740
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTRIGLYCERIDEMIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1289002
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
10761
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278015
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
715874
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1286824
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1192259
CLINICAL STUDIES
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
671401
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69620
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
915003
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
705463
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280216
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
APIGENIN,4'-O-METHYL:
730432
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE SCAVENGING ACTIVITY INCREASE
Ginkgo biloba (GINKGOACEAE)
733794
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
800926
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1295230
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID (C15:1)
401413
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
681211
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
1183003
PHARMACOLOGY OF EXTRACT - IN VIVO
ADRENERGIC RECEPTOR BLOCKER(BETA)
Ginkgo biloba (GINKGOACEAE)
636892
PHARMACOLOGY OF EXTRACT - IN VIVO
ATP-ASE(NA+/K+) STIMULATION
Ginkgo biloba (GINKGOACEAE)
393879
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
775335
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
636677
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
680723
PHARMACOLOGY OF EXTRACT - IN VITRO
GAMMA-GLUTAMYL CYSTEINE SYNTHETASE INDUCTION
Ginkgo biloba (GINKGOACEAE)
693385
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
394724
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
870958
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)
783665
PHARMACOLOGY OF EXTRACT - IN VIVO
GENE EXPRESSION INDUCTION
Ginkgo biloba (GINKGOACEAE)
163057
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
COUMARIN,ISO: 8-HYDROXY-3-TRIDECYL-3-4'-DIHYDRO:
638804
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
278005
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
670627
CLINICAL STUDIES
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
775716
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOID GLYCOSIDES
674936
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
266017
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
COSMOSIIN
1178212
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1167900
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1289645
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
399301
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
673831
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1290790
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN 10 SECRETION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1258302
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673860
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397382
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
922668
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
759001
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
547826
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
626778
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
ANTIFERTILITY EFFECT(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
751569
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
66794
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
695495
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
738686
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
424848
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
PENTACOSANE,N:
628035
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
493099
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) RECEPTOR UPREGULATION
Ginkgo biloba (GINKGOACEAE)
1304101
CLINICAL STUDIESREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
565099
ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
715894
PHARMACOLOGY OF EXTRACT - IN VITRO
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
568670
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789929
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
TAXA-4(20)-11-DIENE,2-ALPHA-5-ALPHA-10-BETA-TRIACETOXY-14-BETA-PROPIONYL-OXY:TAXA-4(20)-11-DIENE,14-BETA-HYDROXY-2-ALPHA-5-ALPHA-10-BETA-TRIACETOXY:TAXA-4(20)-11-DIENE,2-ALPHA-5-ALPHA-10-BETA-TRIACETOXY-14-BETA-(2-METHYL-BUTYRYL)-OXY:TAXA-4(20)-11-DIENE,2-ALPHA-5-ALPHA-DIACETOXY-10-BETA-14-BETA-DIHYDROXY:TAXA-4(20)-11-DIENE,2-ALPHA-5-ALPHA-10-BETA-14-BETA-TETRAACETOXY:TAXA-4(20)-11-DIENE,2-ALPHA-5-ALPHA-14-BETA-TRIACETOXY-10-BETA-HYDROXY:
823482
PHARMACOLOGY OF EXTRACT - IN VITRO
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
900774
PHARMACOLOGY OF EXTRACT - IN VIVO
ALCOHOL DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
867421
X-RAY CHRYSTALLOGRAPHIC STUDIESIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
956530
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
738690
PHARMACOLOGY OF EXTRACT - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
758840
PHARMACOLOGY OF EXTRACT - IN VIVO
CONDITIONED AVOIDANCE RESPONSE DECREASED
Ginkgo biloba (GINKGOACEAE)
902520
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ADRENERGIC AGONIST(ALPHA)
Ginkgo biloba (GINKGOACEAE)
396862
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-[HEPTADEC-CIS-10'-ENYL]:
635172
PHARMACOLOGY OF EXTRACT - IN VIVO
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
352627
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Ginkgo biloba (GINKGOACEAE)
886648
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
1184831
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
535713
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KYNURENIC ACID,6-HYDROXY:
420667
CLINICAL STUDIES
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
806996
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL ADHESION STIMULATION
Ginkgo biloba (GINKGOACEAE)
56956
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE M
742603
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
396851
VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-[PENTADEC-CIS-8'-ENYL]:
874841
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICEREBRAL EDEMA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
550513
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIEMETIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
783535
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
763395
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEQUERCETINGINKGOLIDE JGINKGOLIDE CKAEMPFEROLGINKGOLIDE AGINKGOLIDE BRHAMNETIN,ISO:
1235048
ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR
LABOR INDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
372046
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
PHOSPHOLIPASE A2 ACTIVATION
Ginkgo biloba (GINKGOACEAE)
1293697
PHARMACOLOGY OF EXTRACT - IN VIVO
BIOAVAILABILITY OF
Ginkgo biloba (GINKGOACEAE)
653439
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
547404
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
67730
PRESENT IN (REVIEW)
Ginkgo biloba (GINKGOACEAE)
GINKGOIC ACIDGINKGOLIC ACIDBILOBOLGINKGOL
719476
PHARMACOLOGY OF EXTRACT - IN VIVO
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
451021
PHARMACOLOGY OF EXTRACT - IN VIVO
ACTH LEVEL INCREASE
Ginkgo biloba (GINKGOACEAE)
1287181
PHARMACOLOGY OF EXTRACT - IN HUMANS
MENOPAUSE SYMPTOMS RELIEF
Ginkgo biloba (GINKGOACEAE)
20779
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638797
PHARMACOLOGY OF EXTRACT - IN VITRO
COLLAGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
673852
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
759277
PHARMACOLOGY OF EXTRACT - IN VIVO
VASORELAXATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1291182
PHARMACOLOGY OF EXTRACT - IN VITRO
NEURAMINIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
789065
PHARMACOLOGY OF EXTRACT - IN VITRO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
788803
PHARMACOLOGY OF EXTRACT - IN VIVO
ATP-ASE ACTIVITY PROTECTION
Ginkgo biloba (GINKGOACEAE)
354774
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIPLATELET ACTIVITY
Ginkgo biloba (GINKGOACEAE)
316713
MEDICINAL FOLKLORE REPORTED FOR
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1083444
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
CYCASIN
352232
PHARMACOLOGY OF COMPOUND - IN VIVO
CORTICOSTERONE LEVEL DECREASE
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
760080
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
639679
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
DNA DAMAGE PREVENTION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69087
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
932385
PHARMACOLOGY OF EXTRACT - IN VITRO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
628033
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
676770
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Ginkgo biloba (GINKGOACEAE)
1275950
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
492174
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
736481
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(15:0)
687285
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET ACTIVATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
280205
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
MYRICETIN,4'-O-METHYL: 3-O-(6-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
760406
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMARYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
605123
MEDICINAL FOLKLORE REPORTED FOR
ANTIASTHMATIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1297327
PHARMACOLOGY OF EXTRACT - IN VITRO
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION INHIBITION
Ginkgo biloba (GINKGOACEAE)
688431
HISTORICAL ACCOUNT OF
Ginkgo biloba (GINKGOACEAE)
635000
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
492176
PHARMACOLOGY OF EXTRACT - IN VITRO
INSULIN RELEASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
560960
PHARMACOLOGY OF EXTRACT - IN VITRO
MONOAMINE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
693458
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
43592
COMPLETE SYNTHESIS REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
1167910
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1178343
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
MALONDIALDEHYDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
897455
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLIC AMP PHOSPHODIESTERASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
747175
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
394684
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
882172
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(ALPHA-RHAMNOSYL-(1-2)-ALPHA-RHAMNOSYL-(1-6))-BETA-D-GLUCOSIDE
394619
CLINICAL STUDIES
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
490471
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
396525
PHARMACOLOGY OF EXTRACT - IN VIVO
ADRENERGIC AGONIST(ALPHA)
Ginkgo biloba (GINKGOACEAE)
369682
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
277995
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
551292
MEDICINAL FOLKLORE REPORTED FOR
ANTIASTHMATIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1293621
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
676034
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
962836
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONE
769914
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
634999
CLINICAL STUDIES
ANTIDEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394315
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278031
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
787948
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1007023
QUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
DOCOSAN-1-OL
382606
PHARMACOLOGY OF EXTRACT - IN VIVO
PHARMACOKINETIC ALTERATION
Ginkgo biloba (GINKGOACEAE)
1252768
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR
ANTHELMINTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
644550
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(PENTADEC-CIS-8'-ENYL)
323050
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBANONEEUDESMOL,GAMMA:EUDESMOL,BETA:ELEMOL
652752
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
68678
CLINICAL STUDIES
CHOLINERGIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1300836
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
361928
PHARMACOLOGY OF EXTRACT - IN VIVO
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
803741
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
874489
PHARMACOLOGY OF EXTRACT - IN VIVO
ADRENERGIC AGONIST(BETA)
Ginkgo biloba (GINKGOACEAE)
397376
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1275974
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
392969
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
1273836
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
788830
PHARMACOLOGY OF EXTRACT - IN VIVO
METHOXYRESOFURIN-O-DEMETHYLASE(MROD) STIMULATION
Ginkgo biloba (GINKGOACEAE)
401472
PHARMACOLOGY OF EXTRACT - IN VIVO
RECEPTOR BINDING(GLUCOCORTICOID) DECREASED
Ginkgo biloba (GINKGOACEAE)
927966
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
LARICITRIN-3-O-RUTINOSIDE
454659
IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYTLC DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
497121
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167887
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
678970
PHARMACOLOGY OF EXTRACT - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Ginkgo biloba (GINKGOACEAE)
517024
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
926161
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
870443
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
1158209
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ginkgo biloba (GINKGOACEAE)
1282377
PHARMACOLOGY OF EXTRACT - IN VITRO
GENE INDUCTION
Ginkgo biloba (GINKGOACEAE)
960862
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
69559
PHARMACOLOGY OF EXTRACT - IN HUMANS
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
68907
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
803746
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
686252
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
397393
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69460
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
765082
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
678969
PHARMACOLOGY OF EXTRACT - IN VITRO
MONOAMINE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
426357
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
670697
PHARMACOLOGY OF EXTRACT - IN VIVO
CELL MEMBRANE STABILIZER
Ginkgo biloba (GINKGOACEAE)
644616
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
SUPEROXIDE DISMUTASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
598545
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
86204
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
DIPHENOL,4-4'-(PENTA-CIS-1-CIS-5-DIENE-1-5-DIYNYL):
370231
PHARMACOLOGY OF EXTRACT - IN VIVO
LONGEVITY PROLONGATION
Ginkgo biloba (GINKGOACEAE)
385125
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
965668
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
721505
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
FARNESYL ACETONE
1294133
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
979109
IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
LINOLEIC ACID
1282403
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
398090
PHARMACOLOGY OF EXTRACT - IN VIVO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
704593
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
738682
AGRONOMIC STUDIES REPORTED
Ginkgo biloba (GINKGOACEAE)
652704
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
VENOUS INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
706579
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
715883
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-UNDECYL:OCTADECA-9-12-DIEN-1-ALEICOSANE,N:OCTADECAN-1-AL
359741
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIAGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
670641
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL ARTERIOSCLEROSIS SYMPTOMS DECREASED
Ginkgo biloba (GINKGOACEAE)
280577
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN-5'-GLUCOSIDE
639680
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
695638
PHARMACOLOGY OF EXTRACT - IN VIVO
MONOAMINE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
535220
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
681716
WRITE LETTER FOR SYNTHETIC COMPOUNDREVIEW OF
Ginkgo biloba (GINKGOACEAE)
693388
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
278020
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-RUTINOSIDE
1167876
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697889
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
571528
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MEMBRANE STABILIZER
Ginkgo biloba (GINKGOACEAE)
56963
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE MGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
392294
MEDICINAL FOLKLORE REPORTED FOR
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ginkgo biloba (GINKGOACEAE)
540222
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET ACTIVATING FACTOR BINDING INHIBITION
Ginkgo biloba (GINKGOACEAE)
397134
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673870
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
511743
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPROTEOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167898
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
808544
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1183972
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
BILOBOL
407012
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
UTERINE STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
BILOBOL
684403
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
596504
PMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
277998
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]-7-O-BETA-D-GLUCOPYRANOSIDE
673881
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
396855
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-TRIDECYL:
425636
CLINICAL STUDIESREVIEW OF
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
738693
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
56952
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE MGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
392311
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
962843
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2'''-6-DIRHAMNOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE
766002
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
769913
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
134902
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(2''-O-BETA-D-GLUCOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
1159701
PHARMACOLOGY OF EXTRACT - IN VITRO
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
635092
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
395419
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
COOPER
595894
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
OCTADECA-5-9-12-TRIENOIC ACIDHEXADECANOIC ACID,14-METHYL:OCTADECA-5-9-DIENOIC ACID
755440
PHARMACOLOGY OF EXTRACT - IN VITRO
POTASSIUM CHANNEL ACTIVATION
Ginkgo biloba (GINKGOACEAE)
974680
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
737276
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638241
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1158211
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ginkgo biloba (GINKGOACEAE)
874561
CLINICAL STUDIES
ANTIDEAFNESS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69471
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
803982
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
397329
CLINICAL STUDIES
MICROCEREBRAL CIRCULATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673856
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697921
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
95410
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
673869
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1277720
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGETIN-7''-O-BETA-D-GLUCOPYRANOSIDE
1285364
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ginkgo biloba (GINKGOACEAE)
1301043
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
CARDANOL C-13:0
396529
PHARMACOLOGY OF EXTRACT - IN VITRO
BIOAVAILABILITY OF
Ginkgo biloba (GINKGOACEAE)
355939
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSINBILOBETIN,1-5'-METHOXY:
607494
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
767918
PHARMACOLOGY OF EXTRACT - IN VIVO
BETA-ADRENERGIC RECEPTOR DENSITY DECREASE
Ginkgo biloba (GINKGOACEAE)
352239
PHARMACOLOGY OF COMPOUND - IN VIVO
CORTISOL INCREASE
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
280803
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGO ANTIFUNGAL PEPTIDE GAFP
394370
CLINICAL STUDIESREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
7740
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE-6-PHOSPHATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
538949
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1273227
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
TERPENESFLAVONOIDS
673842
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
538191
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUCOSE UTILIZATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
401471
PHARMACOLOGY OF EXTRACT - IN VIVO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
781696
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
393883
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1283407
PHARMACOLOGY OF EXTRACT - IN VITRO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
396866
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
RESORCINOL,5-[PENTADEC-CIS-8'-ENYL]:
68749
CLINICAL STUDIESREVIEW OF
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
635042
CLINICAL STUDIES
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
760401
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
897459
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE UPTAKE INDUCTION
Ginkgo biloba (GINKGOACEAE)
678976
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
665571
COMPLEMENTARY MEDICINEREVIEW OF
Ginkgo biloba (GINKGOACEAE)
68210
HERBAL INTERACTIONS
Ginkgo biloba (GINKGOACEAE)
948822
PHARMACOLOGY OF EXTRACT - IN VITRO
WBC-MACROPHAGE STIMULANT
Ginkgo biloba (GINKGOACEAE)
394717
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67542
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
470768
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
404005
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
735059
PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
69493
HISTORICAL ACCOUNT OFREVIEW OF
Ginkgo biloba (GINKGOACEAE)
972745
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
564080
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(HEPTADEC-CIS-8-ENYL):
66888
CLINICAL STUDIES
ANTIDEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1198896
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
607291
CLINICAL STUDIES
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
962832
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
512046
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
VIOLAXANTHINLUTEINLUTEIN ESTERCAROTENE,BETA:NEOXANTHIN
741488
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
788770
PHARMACOLOGY OF EXTRACT - IN VITRO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
280238
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
451016
PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY
PROLACTIN STIMULATION
Ginkgo biloba (GINKGOACEAE)
1290788
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1-BETA RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
765087
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
352630
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
927962
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-RUTINOSIDE
416766
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
654625
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1301052
PHARMACOLOGY OF COMPOUND - IN VITRO
HIV PROTEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
BILOBOL C-13:0
1167896
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
424845
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATATLC DATA REPORTEDIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
GINNOL
634924
PHARMACOLOGY OF EXTRACT - IN VIVO
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
394627
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
759000
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
497120
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
393882
PHARMACOLOGY OF EXTRACT - IN HUMANS
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
370229
PHARMACOLOGY OF EXTRACT - IN VIVO
LEARNING ENHANCEMENT
Ginkgo biloba (GINKGOACEAE)
673847
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
683183
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
488737
PHARMACOLOGY OF EXTRACT - IN VITRO
THROMBIN INHIBITION
Ginkgo biloba (GINKGOACEAE)
721506
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
IONONE,BETA:
977813
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ABSORPTION EFFECTS(CUTANEOUS)
Ginkgo biloba (GINKGOACEAE)
394624
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
629456
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
639683
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
SUPEROXIDE DISMUTASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
758106
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
437904
CRUDE DRUG DESCRIPTIONMICROSCOPY OFREVIEW OF
Ginkgo biloba (GINKGOACEAE)
759279
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
NONACOSANE,N:PALMITONEQUERCETINGENKWANINGINKGETIN,ISO:KAEMPFEROLOCTACOSAN-1-OLGINKGETINTRIACONTANOIC ACIDSITOSTEROL,BETA:SCIADOPITYSINRHAMNETIN,ISO:DAUCOSTEROLGINNOL
673858
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
370934
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67614
CLINICAL STUDIES
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
1280784
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
354703
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397360
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
HYDROXIDE RADICAL GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
788801
PHARMACOLOGY OF EXTRACT - IN VITRO
PROLONGATION OF LIFESPAN
Ginkgo biloba (GINKGOACEAE)
1278837
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
870960
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
426360
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
488432
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
476766
PHARMACOLOGY OF COMPOUND - IN HUMANS
CONVULSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PYRIDOXINE,4-O-METHYL:
1139314
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIMUTAGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
639686
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
763431
IDENTIFICATION IN BY HPLCPATENT DESCRIBEDQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
393386
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
752896
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL GROWTH ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
261137
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
638809
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
659857
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
458793
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
798194
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
1279578
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
526213
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
870441
PHARMACOLOGY OF EXTRACT - IN HUMANS
CNS DEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638800
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN FIBRIL(TYPE I)RETICULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
69618
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
393779
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
516187
PLANT TISSUE CULTURE MARKER CODE
Ginkgo biloba (GINKGOACEAE)
686250
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDESFLAVONOID GLYCOSIDES
1304059
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
DRUG ADDICTION INHIBITION
Ginkgo biloba (GINKGOACEAE)
69615
CLINICAL STUDIES
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1179454
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
PROSTAGLANDIN INDUCTION
Ginkgo biloba (GINKGOACEAE)
394736
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
897281
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
682323
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIAGGRESSION EFFECT
Ginkgo biloba (GINKGOACEAE)
763363
PHARMACOLOGY OF EXTRACT - IN VIVO
WOUND HEALING ACCELERATION
Ginkgo biloba (GINKGOACEAE)
370933
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67589
PHARMACOLOGY OF EXTRACT - IN HUMANS
NEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394790
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
885245
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SYRINGETIN-3-O-RUTINOSIDE
1295229
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID (C13:0)
218701
PHARMACOLOGY OF COMPOUND - IN VITRO
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYSACCHARIDE AGINKGO POLYSACCHARIDE B
390170
PATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
796687
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
397367
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
681047
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
803745
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
916011
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
813181
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY TLC
Ginkgo biloba (GINKGOACEAE)
CATECHIN,(+):
392300
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE RADICAL SCAVENGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
802573
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-4 RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
891971
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-(ALPHA-RHAMNOSYL(1-2)ALPHA-RHAMNOSY(1-6))BETA-D-GLUCOSIDE
347662
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1184828
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
393685
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
239291
AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGO GLYCOPROTEIN
69527
CLINICAL STUDIES
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
758240
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
FLAVONE GLYCOSIDES(TOTAL)
917675
PHARMACOLOGY OF EXTRACT - IN HUMANS
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
625982
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN,DIHYDRO:QUERCETINGINKGETIN,ISO:ASTRAGALINQUERCITRIN,ISO:KAEMPFEROLGINKGETINBILOBETINSCIADOPITYSINRHAMNETIN,ISO:APIGENIN
395045
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1183976
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CARDANOL
278028
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
769836
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
SPERM MOTILITY DECREASE
Ginkgo biloba (GINKGOACEAE)
568519
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)
505614
CLINICAL STUDIES
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
710641
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIVERTIGO EFFECT
Ginkgo biloba (GINKGOACEAE)
605124
MEDICINAL FOLKLORE REPORTED FOR
CNS DEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
979112
IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
PALMITIC ACID
280246
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SYRINGARESINOL-4'-O-BETA-D-GLUCOSIDE
789422
PHARMACOLOGY OF EXTRACT - IN VIVO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
729494
PATENT DESCRIBEDPHARMACEUTICAL FORMULATION OF
Ginkgo biloba (GINKGOACEAE)
760371
PHARMACOLOGY OF EXTRACT - IN VIVO
ATP-ASE ACTIVITY PROTECTION
Ginkgo biloba (GINKGOACEAE)
955356
PHARMACOLOGY OF EXTRACT - IN VIVO
NEURAL PLASTICITY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1167885
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
7612
PHARMACOLOGY OF EXTRACT - IN HUMANS
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
134905
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-[2''-O-6'''-O-{PARA-(7''''-O-BETA-D-GLUCOPYRANOSYL}-COUMAROYL)-BETA-D-GLUCOPYRANOSYL]-ALPHA-L-RHAMNOPYRANOSIDE
316715
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394789
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
673879
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
66670
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
1276013
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
652701
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
738799
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
652706
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
VISION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
743892
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
803234
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONE GLYCOSIDES
607638
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
625853
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1304023
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
EJACULATION RETARDANT
Ginkgo biloba (GINKGOACEAE)
788832
PHARMACOLOGY OF EXTRACT - IN VIVO
P-NITROPHENOL HYDROXYLASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
697936
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
395421
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CHROMIUM
896756
TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
DERMATITIS PRODUCING EFFECT
Ginkgo biloba (GINKGOACEAE)
950212
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
764296
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
1276499
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1291880
CLINICAL STUDIES
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
607640
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
590051
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYSACCHARIDE
874488
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
505320
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
697925
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
COUMARIC ACID,PARA:
6934
PHARMACOLOGY OF COMPOUND - IN VIVOCARCINOGENIC DATA (MARKER CODE)
CARCINOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
659859
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE JGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
397371
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
714736
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
397356
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
635003
CLINICAL STUDIES
BLOOD VISCOSITY DECREASED
Ginkgo biloba (GINKGOACEAE)
1276661
CLINICAL STUDIES
VISION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
783663
PHARMACOLOGY OF EXTRACT - IN HUMANS
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
782806
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
635027
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
724724
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLRHAMNETIN,ISO:
705459
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
400362
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
686689
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
904752
PHARMACOLOGY OF EXTRACT - IN VIVO
MUSCARINIC RECEPTOR INCREASE
Ginkgo biloba (GINKGOACEAE)
395638
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDES
361919
PHARMACOLOGY OF EXTRACT - IN HUMANS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
69430
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
280235
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
699563
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
870946
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-PENTADECENYL:
1190083
CLINICAL STUDIES
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
705464
PHARMACOLOGY OF EXTRACT - IN VIVO
VASCULAR PERMEABILITY DECREASED
Ginkgo biloba (GINKGOACEAE)
280225
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
361920
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
924076
CLINICAL STUDIES
CHRONOTROPIC EFFECT POSITIVE
Ginkgo biloba (GINKGOACEAE)
634953
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
767952
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDSURUSHIOLSCARDANOLS
962835
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
564077
PHARMACOLOGY OF COMPOUND - IN VITRO
GLYCEROL-3-PHOSPHATE DEHYDROGENASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(PENTADEC-CIS-8-ENYL):
362497
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
501168
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
278012
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
714174
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
733795
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
609666
PHARMACOLOGY OF EXTRACT - IN VIVO
ANXIETY INDUCTION
Ginkgo biloba (GINKGOACEAE)
635084
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
726001
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPHAGE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
647072
PHARMACOLOGY OF EXTRACT - IN VIVO
CORTICOSTERONE-INDUCTION
Ginkgo biloba (GINKGOACEAE)
1183002
PHARMACOLOGY OF EXTRACT - IN VIVO
ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)
Ginkgo biloba (GINKGOACEAE)
1323891
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
488734
PHARMACOLOGY OF EXTRACT - IN VIVO
HAIR STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
261132
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
1301054
PHARMACOLOGY OF COMPOUND - IN VITRO
HIV PROTEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
ALKYLSALICYLIC ACID C-17:1
686229
PHARMACOLOGY OF EXTRACT - IN VIVO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
934842
PHARMACOLOGY OF EXTRACT - IN VIVO
LEARNING ENHANCEMENT
Ginkgo biloba (GINKGOACEAE)
714881
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
444707
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) UPTAKE STIMULATION
Ginkgo biloba (GINKGOACEAE)
43593
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SESAMIN,(+):
623566
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROTEINTANNINFLAVONES
626656
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDYREVIEW OF
Ginkgo biloba (GINKGOACEAE)
VITAMIN B-6
962830
CLINICAL STUDIES
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
636676
PHARMACOLOGY OF EXTRACT - IN VIVO
CATALASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
670712
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIARRHYTHMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
642233
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIASTHMATIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
794481
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
396761
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280214
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
APIGENIN
824137
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ginkgo biloba (GINKGOACEAE)
445504
PHARMACOLOGY OF COMPOUND - IN VIVO
SLEEPING TIME DECREASED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
354098
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE FORMATION INDUCTION
Ginkgo biloba (GINKGOACEAE)
885242
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETOL,ISO: 3-O-RUTINOSIDE
398119
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
850672
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KYNURENIC ACID,6-HYDROXY:
278023
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
RUTIN
695492
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
443700
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROEXCITATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
638799
PHARMACOLOGY OF COMPOUND - IN VITRO
COLLAGEN SYNTHESIS STIMULATION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
622953
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:PROTOCATECHUIC ACIDPYROCATECHOLGINKGOLIDE CGINKGOLIDE AGINKGETINGINKGOLIDE BSCIADOPITYSINDAUCOSTEROL
363485
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROANTHOCYANIDIN
971890
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
678978
PHARMACOLOGY OF COMPOUND - IN VIVO
MONOAMINE OXIDASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
1299131
PHARMACOLOGY OF COMPOUND - IN VITRO
NEUROTROPIC EFFECT
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
803770
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
794712
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOCHOLESTEROLEMIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
398098
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
397331
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
511745
PHARMACOLOGY OF EXTRACT - IN VIVO
CORTICOSTERONE-INDUCTION
Ginkgo biloba (GINKGOACEAE)
551300
PHARMACOLOGY OF EXTRACT - IN VITRO
CHOLECYSTOKININ RECEPTOR BINDING EFFECT
Ginkgo biloba (GINKGOACEAE)
747176
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
504825
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
786220
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
393663
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
639677
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
LIPID PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
870954
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
697918
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PROTOCATECHUIC ACID
589631
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
747181
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
QUERCETINRUTINRHAMNETIN,ISO:CHRYSIN
871865
PRESENT IN (REVIEW)
Ginkgo biloba (GINKGOACEAE)
VANILLIC ACIDBENZOIC ACID,4-HYDROXY:QUERCETINPROTOCATECHUIC ACIDGINKGOLIDE CKAEMPFEROLGINKGOLIDE AGINKGOLIDE BRHAMNETIN,ISO:
7805
PMR SPECTRUM REPORTEDQUANTITATIVE DATAYIELD IS LESS THAN 50 MGMISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBETIN
69561
CLINICAL STUDIES
ANTIVITILIGO EFFECT
Ginkgo biloba (GINKGOACEAE)
635073
CLINICAL STUDIES
PLATELET ATP RELEASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
788790
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
69157
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
396859
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-[PENTADEC-CIS-8'-ENYL]:
278003
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-BALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
352234
PHARMACOLOGY OF COMPOUND - IN VIVO
TESTOSTERONE LEVEL DECREASED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
638811
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETIN
798224
AGRONOMIC STUDIES REPORTED
Ginkgo biloba (GINKGOACEAE)
68761
CLINICAL STUDIES
SLEEP TIME INCREASED
Ginkgo biloba (GINKGOACEAE)
802871
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
1167904
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69532
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
1281278
CLINICAL STUDIES
Ginkgo biloba (GINKGOACEAE)
635210
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
574021
PHARMACOLOGY OF EXTRACT - IN VITRO
DNA-BINDING INHIBITION
Ginkgo biloba (GINKGOACEAE)
1178924
PHARMACOLOGY OF EXTRACT - IN VIVO
MALONDIALDEHYDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
630344
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
458792
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
697932
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
CHLOROGENIC ACID
1290642
PHARMACOLOGY OF EXTRACT - IN HUMANS
DIABETIC NEPHROPATHY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
673868
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
630327
PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBED
NITRIC OXIDE SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
1031553
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOL
371232
PHARMACOLOGY OF EXTRACT - IN VITRO
PLASMINOGEN ACTIVATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
391511
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
60454
CLINICAL STUDIES
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
280206
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
MEGASTIGM-TRANS-7-EN-9-ONE,2-BETA-3-ALPHA-DIHYDROXY:
638806
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SCIADOPITYSIN
76526
PHARMACOLOGY OF EXTRACT - IN VIVO
CONVULSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
693387
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
758058
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT POSITIVE
Ginkgo biloba (GINKGOACEAE)
69339
CLINICAL STUDIES
ANTIALZHEIMER'S ACTIVITY
Ginkgo biloba (GINKGOACEAE)
411149
PHARMACOLOGY OF EXTRACT - IN VIVO
AUDITORY DAMAGE PREVENTION
Ginkgo biloba (GINKGOACEAE)
667155
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
397353
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
750139
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
982826
IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
PROPIONIC ACIDPYRUVIC ACIDCITRIC ACIDMALIC ACIDACETIC ACIDLACTIC ACIDGLUTARIC ACID,ALPHA-KETO:FORMIC ACIDSUCCINIC ACID
323049
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
ATLANTONE,(Z):ATLANTONE,10-11-DIHYDRO: (Z):ATLANTONE,10-11-DIHYDRO-6-OXO: (E):ATLANTONE,10-11-DIHYDRO: (E):ATLANTONE,(E):
395414
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOID GLYCOSIDES
7527
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
789085
PHARMACOLOGY OF COMPOUND - IN VITRO
LACTATE DEHYDROGENASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
280249
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
LUTEOLIN-3'-O-BETA-D-GLUCOSIDE
647233
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
HEPTADEC-3-EN-2-ONE
69124
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
654603
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOPROTECTIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67055
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
365408
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTISTRESS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
603330
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69223
PHARMACOLOGY OF EXTRACT - IN VITRO
METABOLISM OF
Ginkgo biloba (GINKGOACEAE)
837804
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
CEREBRAL ARTERIOSCLEROSIS SYMPTOMS DECREASED
Ginkgo biloba (GINKGOACEAE)
68971
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
397364
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394368
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1301041
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
CARDANOL C-15:1
397345
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
634693
PHARMACOLOGY OF EXTRACT - IN VIVO
SEROTONIN (5-HT) ANTAGONIST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278026
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORIN
699566
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
650734
PHARMACOLOGY OF EXTRACT - IN VITRO
MUSCLE EFFECTS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
1276020
PHARMACOLOGY OF EXTRACT - IN VIVO
PULMONARY EDEMA PROTECTION
Ginkgo biloba (GINKGOACEAE)
517641
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
535219
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278030
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCITRIN,ISO:
394861
CLINICAL STUDIESREVIEW OF
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
962841
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RUTIN
67805
CLINICAL STUDIES
ANTIPSYCHOTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
874484
CLINICAL STUDIES
ANTISHOCK EFFECT
Ginkgo biloba (GINKGOACEAE)
647129
PHARMACOLOGY OF EXTRACT - IN VIVO
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
874472
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1167874
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
974679
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
361925
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
767799
PHARMACOLOGY OF EXTRACT - IN VIVO
COLLAGEN SYNTHESIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
363189
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
760399
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
181936
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GLYCEROL,THREO-GUAIACYL: (DL):
667193
PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
GINKOTOXIN
391500
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
786225
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:
915002
PHARMACOLOGY OF EXTRACT - IN VIVO
LACTATE INDUCTION
Ginkgo biloba (GINKGOACEAE)
280217
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
MYRICETIN
705460
PHARMACOLOGY OF EXTRACT - IN VIVO
VASCULAR PERMEABILITY DECREASED
Ginkgo biloba (GINKGOACEAE)
67732
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ALLERGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
67044
CLINICAL STUDIESREVIEW OF
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
681967
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
954785
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN
758243
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
394872
PHARMACOLOGY OF EXTRACT - IN VITRO
CHOLINERGIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673851
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
687274
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
697929
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FERULIC ACID
605127
MEDICINAL FOLKLORE REPORTED FOR
ANTIASTHMATIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278017
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNPYRANOSIDE
478146
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
POLYPRENOL 85POLYPRENOL 95POLYPRENOL 90
687281
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
784436
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FORIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID C-15:1GINKGOLIC ACID C-17:1GINKGOLIC ACID C-15:0GINKGOLIC ACID C-17:2GINKGOLIC ACID C-13:0
368527
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLRHAMNETIN,ISO:
391497
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE J
7422
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CATECHIN,(+):CATECHIN,EPI: (-):GALLOCATECHIN,(+):CATECHIN,EPI-GALLO: (-):
882173
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-(ALPHA-RHAMNOSYL-(1-2)-ALPHA-RHAMNOSYL-(1-6))-BETA-GLUCOSIDE
902507
PHARMACOLOGY OF EXTRACT - IN VIVO
VASODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
870957
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-2-RHAMNOSIDE)
736480
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(13:0)
371090
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
1178211
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
738800
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
393348
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
492175
PHARMACOLOGY OF EXTRACT - IN VIVO
INSULIN RELEASE STIMULATION
Ginkgo biloba (GINKGOACEAE)
1178342
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ANTIHYPERTENSIVE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1193217
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
670640
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIATHEROSCLEROTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
370230
PHARMACOLOGY OF EXTRACT - IN VIVO
LEARNING ENHANCEMENT
Ginkgo biloba (GINKGOACEAE)
68748
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1167903
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1304392
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIMIGRAINE EFFECT
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
902521
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
LACTATE INHIBITION
Ginkgo biloba (GINKGOACEAE)
673850
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
278004
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
261140
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKBILOBIN
1198895
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
470767
ARTICLE OF INTEREST TO THE HERB INDUSTRYREVIEW OF
Ginkgo biloba (GINKGOACEAE)
678643
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY RETENTION IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
763429
IDENTIFICATION IN BY HPLCQUANTITATIVE DATAPATENT DESCRIBED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
1192263
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
958251
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR CONDITIONER
Ginkgo biloba (GINKGOACEAE)
626779
PHARMACOLOGY OF EXTRACT - IN VITRO
MUTAGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673832
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
769915
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDSGINKGOLIC ACID,HYDRO:
962839
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-(6'''-O-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)ALPHA-L-RHAMNOPYRANOSIDE)
1297900
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
517584
PHARMACOLOGY OF EXTRACT - IN VIVO
FIBRINOLYTIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
738692
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUCOSE UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
962834
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:
637560
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
897456
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLIC AMP PHOSPHODIESTERASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
393858
ISOLATION AND IDENTIFICATION OFREVIEW OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
280228
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
671365
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
385962
MEDICINAL FOLKLORE REPORTED FOR
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ginkgo biloba (GINKGOACEAE)
634990
CLINICAL STUDIES
PHARMACOKINETIC STUDY OF
Ginkgo biloba (GINKGOACEAE)
766444
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
397348
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
ADRENERGIC AGONIST(ALPHA)
Ginkgo biloba (GINKGOACEAE)
95407
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
564076
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-(PENTADEC-CIS-8-ENYL):
737184
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDESFLAVONOIDS
397375
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
608732
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITHROMBOTIC EFFECT
Ginkgo biloba (GINKGOACEAE)
758059
PHARMACOLOGY OF EXTRACT - IN VITRO
CARDIOTONIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673886
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1007027
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
AFZELIN
280241
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-RHAMNOGLUCOSIDE
765079
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
762788
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
747593
PHARMACOLOGY OF EXTRACT - IN VITRO
VASORELAXATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673882
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
380600
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1167888
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1178920
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1304062
REVIEW OF
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
352238
PHARMACOLOGY OF COMPOUND - IN VIVO
GENE EXPRESSION INDUCTION
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE AGINKGOLIDE B
394776
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1158210
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ginkgo biloba (GINKGOACEAE)
403015
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1178345
PHARMACOLOGY OF EXTRACT - IN VIVO
CEREBRAL EDEMA DECREASED
Ginkgo biloba (GINKGOACEAE)
280801
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGO ANTIFUNGAL PEPTIDE GAFP
488433
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
982838
IDENTIFICATION IN BY GLC AFTER SAPONIFICATIONQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
PALMITIC ACID,ALPHA-HYDROXY:LINOLEIC ACIDOLEIC ACID
450905
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
715879
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-UNDECYL:OCTADECA-9-12-DIEN-1-ALEICOSANE,N:OCTADECAN-1-AL
404394
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE AGINKGOLIDE B
673855
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1301046
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
BILOBOL C-13:0
391515
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
629465
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
68906
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1295231
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(C7:1)
1295350
CLINICAL STUDIES
CORONARY BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
487951
CLINICAL STUDIES
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673864
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
716468
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
280230
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
163058
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
COUMARIN,ISO: 8-HYDROXY-3-HEPTADECYL-3-4-DIHYDRO:
523240
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
372045
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
SUPEROXIDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
394678
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
882171
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
395417
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOID GLYCOSIDES
647234
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
HEPTADEC-3-EN-2-ONE
975634
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
697922
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
CAFFEIC ACID
695739
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIECZEMA EFFECT
Ginkgo biloba (GINKGOACEAE)
729128
PHARMACOLOGY OF EXTRACT - IN VIVO
ANGIOTENSIN-CONVERTING ENZYME INHIBITION
Ginkgo biloba (GINKGOACEAE)
394718
CLINICAL STUDIES
VESTIBULAR COMPENSATION INCREASE
Ginkgo biloba (GINKGOACEAE)
759067
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
69580
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
742628
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
639030
CLINICAL STUDIES
ANTIVERTIGO EFFECT
Ginkgo biloba (GINKGOACEAE)
710991
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
1017895
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MEMBRANE STABILIZER
Ginkgo biloba (GINKGOACEAE)
512155
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
598543
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
673861
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
800740
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
395081
IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
ANACARDIC ACID (17:0)ANACARDIC ACID (15:0)ANACARDIC ACID (13:1)ANACARDIC ACID (17:1)ANACARDIC ACID (15:3)FATTY ACIDS(UNSATURATED)ANACARDIC ACID (17:2)ANACARDIC ACID (13:2)ANACARDIC ACID (15:2)ANACARDIC ACID (17:3)ANACARDIC ACID (15:1)ANACARDIC ACID (13:0)
715882
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
PHENOL,3-UNDECYL:OCTADECA-9-12-DIEN-1-ALEICOSANE,N:OCTADECAN-1-AL
396865
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RESORCINOL,5-[PENTADEC-CIS-8'-ENYL]:
802873
PHARMACOLOGY OF EXTRACT - IN VIVO
SOMATOSTATIN INDUCTION
Ginkgo biloba (GINKGOACEAE)
491824
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
QUERCETIN
886702
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
681476
PHARMACOLOGY OF EXTRACT - IN VIVO
CARDIOTONIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1304102
CLINICAL STUDIESREVIEW OF
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
445499
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
551295
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673871
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
69341
CLINICAL STUDIES
PLATELET ACTIVATING FACTOR INHIBITION
Ginkgo biloba (GINKGOACEAE)
1301047
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
ALKYLSALICYLIC ACID C-15:1
1300837
PHARMACOLOGY OF EXTRACT - IN VIVO
BETA-SECRETASE ENZYME INHIBITION
Ginkgo biloba (GINKGOACEAE)
401464
PHARMACOLOGY OF EXTRACT - IN VITRO
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
874570
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
66740
CLINICAL STUDIES
BLOOD FLOW INCREASE
Ginkgo biloba (GINKGOACEAE)
396870
PHARMACOLOGY OF COMPOUND - IN VITRO
PHOSPHOLIPASE C INHIBITION
Ginkgo biloba (GINKGOACEAE)
GREVILLOL
181935
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GLYCEROL,DL-THREO-PARA-HYDROXY-PHENYL:KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE]
972749
PHARMACOLOGY OF EXTRACT - IN HUMANS
CEREBRAL BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
361921
PHARMACOLOGY OF EXTRACT - IN VIVO
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
971759
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
678980
PHARMACOLOGY OF COMPOUND - IN VITRO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL
927967
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
RUTIN
1273837
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INHIBITION
Ginkgo biloba (GINKGOACEAE)
859030
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
AMPELOPSIN,(+):LEUCODELPHINIDIN
671400
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
792050
PHARMACOLOGY OF EXTRACT - IN VITRO
PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
395418
QUANTITATIVE DATAIDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SELENIUM
278001
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-BALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
546187
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
391504
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
45278
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE C
1289003
PHARMACOLOGY OF EXTRACT - IN VIVO
MALONDIALDEHYDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
352227
PHARMACOLOGY OF EXTRACT - IN VIVO
ACTH LEVEL DECREASE
Ginkgo biloba (GINKGOACEAE)
1299362
PHARMACOLOGY OF EXTRACT - IN VIVO
BLOOD FLOW DECREASE
Ginkgo biloba (GINKGOACEAE)
66792
CLINICAL STUDIES
FIBRINOGEN LEVEL DECREASED
Ginkgo biloba (GINKGOACEAE)
68770
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1281169
PHARMACOLOGY OF EXTRACT - IN HUMANS
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
554430
PHARMACOLOGY OF EXTRACT - IN VIVO
METABOLISM OF
Ginkgo biloba (GINKGOACEAE)
1283560
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHROTOXIC
Ginkgo biloba (GINKGOACEAE)
278014
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-RHAMNOPYRANOSIDE
823479
PHARMACOLOGY OF EXTRACT - IN VITRO
VASOCONSTRICTOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
397392
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
CEREBRAL INSUFFICIENCY IMPROVEMENT
Ginkgo biloba (GINKGOACEAE)
394739
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
783666
PHARMACOLOGY OF EXTRACT - IN VIVO
GENE EXPRESSION INDUCTION
Ginkgo biloba (GINKGOACEAE)
800925
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280802
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
GINKGO ANTIFUNGAL PEPTIDE GAFP
547825
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
424849
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Ginkgo biloba (GINKGOACEAE)
TRICOSANE,N:
391493
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
644721
CLINICAL STUDIES
CIRCULATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
571542
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167913
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789081
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID
639676
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
426356
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
BILOBALIDE
673843
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
487922
PHARMACOLOGY OF EXTRACT - IN VITRO
PEROXIDE FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
69619
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
765083
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1276339
PHARMACOLOGY OF EXTRACT - IN VITRO
METABOLISM OF
Ginkgo biloba (GINKGOACEAE)
674935
MASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACIDS
1285597
PHARMACOLOGY OF EXTRACT - IN VITRO
GENE INDUCTION
Ginkgo biloba (GINKGOACEAE)
394955
PHARMACOLOGY OF EXTRACT - IN VIVO
DERMATITIS PRODUCING EFFECT
Ginkgo biloba (GINKGOACEAE)
66793
CLINICAL STUDIES
CELL CONTENT RELEASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
278006
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOCHROME C REDUCTION EFFECT
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
670636
PHARMACOLOGY OF EXTRACT - IN VIVO
AUDITORY DAMAGE PREVENTION
Ginkgo biloba (GINKGOACEAE)
69492
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1297328
PHARMACOLOGY OF EXTRACT - IN VITRO
FOAM CELL FORMATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
922669
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO:
1167907
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
559392
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICLASTOGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
393288
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
KYNURENIC ACID,6-HYDROXY:
369683
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
714590
PLANT TISSUE CULTURE MARKER CODEMICROBIAL TRANSFORMATION OF
Ginkgo biloba (GINKGOACEAE)
SINENXAN A
654795
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
1277721
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGETIN,ISO: 7-O-BETA-D-GLUCOPYRANOSIDE
571529
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1288827
PHARMACOLOGY OF EXTRACT - IN VITRO
CALCIUM LEVEL INCREASE(INTRACELLULAR)
Ginkgo biloba (GINKGOACEAE)
635174
PHARMACOLOGY OF EXTRACT - IN VIVO
BARBITURATE SLEEPING TIME DECREASED
Ginkgo biloba (GINKGOACEAE)
725997
VOUCHER SPECIMEN REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
7479
PHARMACOLOGY OF EXTRACT - IN VITRO
BRADYKININ ANTAGONIST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
802845
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
1184830
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
1007022
IDENTIFICATION IN BY GLC
Ginkgo biloba (GINKGOACEAE)
ARACHIDIC ACIDMYRISTIC ACIDSTEARIC ACIDPALMITIC ACIDBEHENIC ACIDSTIGMASTEROLLAURIC ACIDSITOSTEROL,BETA:INGNOCERIC ACID
681231
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
803969
PHARMACOLOGY OF EXTRACT - IN VIVO
LUNG PROBLEMS(UNSPECIFIED)
Ginkgo biloba (GINKGOACEAE)
678973
PHARMACOLOGY OF EXTRACT - IN VIVO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Ginkgo biloba (GINKGOACEAE)
1176928
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
DESMUTAGENIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167899
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
421535
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN DEGRADATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
349388
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ginkgo biloba (GINKGOACEAE)
800356
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
BILOBALIDEGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
667171
PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
359434
PHARMACOLOGY OF EXTRACT - IN VIVO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
485077
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
763026
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
488733
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
277999
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]-7-O-BETA-D-GLUCOPYRANOSIDE
475635
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
RUTIN
806995
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL PROLIFERATION STIMULATION
Ginkgo biloba (GINKGOACEAE)
1295371
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHROTOXIC
Ginkgo biloba (GINKGOACEAE)
394387
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
789077
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394623
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
954457
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUCOSE UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
804965
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
ESTROGENIC EFFECT
Ginkgo biloba (GINKGOACEAE)
1158214
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ginkgo biloba (GINKGOACEAE)
497123
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
598546
IDENTIFICATION IN BY HPLC
Ginkgo biloba (GINKGOACEAE)
GINKGOTOXIN
940957
PHARMACOLOGY OF EXTRACT - IN VITRO
BRONCHODILATOR ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1288830
CLINICAL STUDIES
CORONARY BLOOD FLOW INCREASED
Ginkgo biloba (GINKGOACEAE)
1280789
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
76529
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXIC EFFECT(GENERAL)
Ginkgo biloba (GINKGOACEAE)
PYRIDOXINE,4'-METHOXY:
398100
PHARMACOLOGY OF EXTRACT - IN VITRO
SEROTONIN (5-HT) UPTAKE INHIBITION
Ginkgo biloba (GINKGOACEAE)
1293577
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
673835
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394334
PHARMACOLOGY OF EXTRACT - IN HUMANS
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
794714
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERPLASIA INDUCTION
Ginkgo biloba (GINKGOACEAE)
69582
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
355754
PHARMACOLOGY OF EXTRACT - IN VITRO
NITRIC ACID SYNTHASE INHIBITION
Ginkgo biloba (GINKGOACEAE)
592046
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTINEUROTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280245
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
QUERCETIN-3-GLUCORHAMNOSIDE
391509
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
710994
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
PLATELET AGGREGATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
715875
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
654629
PHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
993317
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-BETA-D-RUTINOSIDE
802534
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
655554
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONOIDS
1027442
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR
Ginkgo biloba (GINKGOACEAE)
AMENTOFLAVONEGINKGETIN,ISO:GINKGETINBILOBETINSCIADOPITYSIN
972916
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
HAIR STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
394630
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
69553
PHARMACOLOGY OF EXTRACT - IN HUMANS
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
280234
ISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
ASTRAGALIN
1299480
PHARMACOLOGY OF EXTRACT - IN VIVO
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
394793
CLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
769918
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
69481
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
404004
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROXIDE RADICAL GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
398286
AGRONOMIC STUDIES REPORTED
Ginkgo biloba (GINKGOACEAE)
801834
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
394714
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
605120
MEDICINAL FOLKLORE REPORTED FOR
ANTIMYCOBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1167893
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
697926
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
COUMARIC ACID,PARA:
397372
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIAGING ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1303597
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
DRUG INTERACTION
Ginkgo biloba (GINKGOACEAE)
706580
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
397381
PHARMACOLOGY OF EXTRACT - IN VIVOREVIEW OF
NEUROPROTECTANT EFFECT
Ginkgo biloba (GINKGOACEAE)
789419
PHARMACOLOGY OF EXTRACT - IN VITRO
SEROTONIN (5-HT) SECRETION INHIBITION
Ginkgo biloba (GINKGOACEAE)
1260729
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
INSECTICIDE ACTIVITY
Ginkgo biloba (GINKGOACEAE)
760402
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
KAEMPFEROL-3-O-ALPHA-(6'''-PARA-COUMAROYL-GLUCOSYL-BETA-1-4-RHAMNOSIDE)
1167877
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
788183
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
681956
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
PHENOLIC ACIDSFLAVONOIDS
673875
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1182823
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE INHIBITION
Ginkgo biloba (GINKGOACEAE)
277996
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Ginkgo biloba (GINKGOACEAE)
RHAMNETIN,ISO: 3-O-ALPHA-L-[6'''-PARA-COUMAROYL-BETA-D-GLUCOPYRANOSYL(1-2)-RHAMNOPYRANOSIDE]
897737
PHARMACOLOGY OF EXTRACT - IN HUMANS
VISUAL EFFECTS
Ginkgo biloba (GINKGOACEAE)
397359
PHARMACOLOGY OF EXTRACT - IN VITROREVIEW OF
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1289614
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ginkgo biloba (GINKGOACEAE)
551299
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTAMATE RECEPTOR BLOCKER
Ginkgo biloba (GINKGOACEAE)
397133
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ginkgo biloba (GINKGOACEAE)
280220
PHARMACOLOGY OF COMPOUND - IN VITRO
REACTIVE OXYGEN SPECIES GENERATION INHIBITION
Ginkgo biloba (GINKGOACEAE)
TAMARIXETIN
370928
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,N-HEPTADECENYL:SALICYLIC ACID,N-HEPTADECYL:SALICYLIC ACID,N-PENTADECENYL:SALICYLIC ACID,N-TRIDECYL:SALICYLIC ACID,N-PENTADECYL:
630325
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
COSMETIC EFFECTS
Ginkgo biloba (GINKGOACEAE)
756039
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDES
683161
IDENTIFICATION OFQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
FLAVONESLACTONES
874562
CLINICAL STUDIES
ANTITINNITUS ACTIVITY
Ginkgo biloba (GINKGOACEAE)
982839
ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT
Ginkgo biloba (GINKGOACEAE)
OCTADECASPHINGADIENE,N-ALPHA-HYDROXY-PALMITOYL-GLUCOSYL:
670083
PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
QUERCETINKAEMPFEROLRUTIN
460294
ARTICLE OF INTEREST TO THE HERB INDUSTRY
Ginkgo biloba (GINKGOACEAE)
396861
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
SALICYLIC ACID,6-[HEPTADEC-CIS-10'-ENYL]:
407013
PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY
UTERINE STIMULANT EFFECT
Ginkgo biloba (GINKGOACEAE)
BILOBOL
1167882
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1183971
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
BILOBOL
1300833
PHARMACOLOGY OF EXTRACT - IN VITRO
BETA-SECRETASE ENZYME INHIBITION
Ginkgo biloba (GINKGOACEAE)
257814
PLANT TISSUE CULTURE MARKER CODEISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ginkgo biloba (GINKGOACEAE)
GINKGO POLYSACCHARIDE ECP-3GINKGO POLYSACCHARIDE ICP-2GINKGO POLYSACCHARIDE ECP-1GINKGO POLYSACCHARIDE ICP-1GINKGO POLYSACCHARIDE ECP-2
806559
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
736485
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Ginkgo biloba (GINKGOACEAE)
GINKGOLIC ACID(17:3)
69513
CLINICAL STUDIES
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
505318
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
CNS EFFECTS(GENERAL)
Ginkgo biloba (GINKGOACEAE)
763536
REVIEW OF
Ginkgo biloba (GINKGOACEAE)
57894
STRUCTURE DETERMINATION OFISOLATION AND IDENTIFICATION OF
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE MGINKGOLIDE CGINKGOLIDE AGINKGOLIDE B
56953
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE A
789066
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
394725
CLINICAL STUDIES
ANTIDEPRESSANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1288826
PHARMACOLOGY OF EXTRACT - IN VITRO
VASORELAXATION ACTIVITY
Ginkgo biloba (GINKGOACEAE)
634971
CLINICAL STUDIES
COGNITIVE ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)
1030434
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
896487
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIDEMENTIA ACTIVITY
Ginkgo biloba (GINKGOACEAE)
758065
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPARKINSON ACTIVITY
Ginkgo biloba (GINKGOACEAE)
802577
PHARMACOLOGY OF EXTRACT - IN VITRO
ACTIVATOR PROTEIN 1 INHIBITION
Ginkgo biloba (GINKGOACEAE)
444344
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIISCHEMIC EFFECT
Ginkgo biloba (GINKGOACEAE)
517023
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ginkgo biloba (GINKGOACEAE)
43055
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ginkgo biloba (GINKGOACEAE)
GINKGOLIDE B
699567
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1282844
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ginkgo biloba (GINKGOACEAE)
1298001
CLINICAL STUDIES
MISCELLANEOUS EFFECTS
Ginkgo biloba (GINKGOACEAE)
490511
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Ginkgo biloba (GINKGOACEAE)
NICOTIFLORINQUERCETIN-3-O-PARA-COUMAROYL-GLUCO-RHAMNOSIDEKAEMPFEROL-3-O-PARA-COUMAROYL-GLUCO-RHAMNOSIDERUTINRHAMNETIN,ISO: 3-O-RUTINOSIDEKAEMPFEROL-2-6-DIRHAMNOSYL-GLUCOSIDE
67381
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
MEMORY ENHANCEMENT EFFECT
Ginkgo biloba (GINKGOACEAE)